Toxicology – Acute Visual Loss and Visual Disturbances

Core Concept

Acute visual disturbance after a toxic exposure can result from injury anywhere along the visual pathway, including:

• Cornea and conjunctiva
• Lens
• Retina
• Optic nerve
• Central visual pathways
• Extraocular muscles and their innervation

Symptoms can range from mild blurring or abnormal color perception to visual-field loss or complete blindness.

Sudden visual loss is an ophthalmologic emergency until a serious ocular, neurologic, vascular, or toxic cause has been excluded.

Major Toxicologic Causes

Methanol

Methanol is one of the most important toxicologic causes of acute visual impairment.

Methanol is metabolized to formic acid, which produces metabolic acidosis and is particularly toxic to the retina and optic nerve.

Visual complaints may include:

• Blurred vision
• Reduced visual acuity
• Central visual defects
• Photophobia
• “Snowfield” or “snowstorm” vision
• Severe visual loss or blindness

Systemic findings may include:

• Headache
• Nausea/vomiting
• Abdominal discomfort
• CNS depression
• High-anion-gap metabolic acidosis
• Tachypnea

Severe poisoning can progress to seizures, coma, cardiovascular instability, and permanent blindness.

Methanol: Important Diagnostic Pattern

A particularly concerning combination is:

Visual disturbance + unexplained high-anion-gap metabolic acidosis

The osmolal gap may be elevated early but can become normal later as methanol is converted to toxic metabolites.

Therefore:

A normal osmolal gap does not exclude late methanol poisoning.

Direct methanol measurement is preferred when available.

Methanol Management

Important treatment principles include:

• Stabilization and supportive care
• Inhibition of toxic alcohol metabolism with fomepizole
• Correction of clinically important acidosis
• Folate-related adjunctive therapy in appropriate cases
• Hemodialysis for selected severe poisoning

Visual symptoms are an important marker of serious methanol toxicity and warrant urgent toxicology involvement.

Quinine and Related Drugs

Quinine toxicity can cause significant ocular toxicity.

Possible manifestations include:

• Blurred vision
• Reduced visual acuity
• Constricted visual fields
• Altered color vision
• Scotomas
• Severe visual impairment

Systemic features of quinine toxicity may include:

• Tinnitus
• Hearing disturbance
• Dizziness
• Nausea/vomiting
• Headache
• Dysrhythmias

The combination of tinnitus and visual abnormalities can be an important clue.

Chloroquine and Hydroxychloroquine

These agents can affect vision through different mechanisms depending on the exposure pattern.

Severe acute chloroquine/hydroxychloroquine poisoning is primarily characterized by:

• Hypotension
• Hypokalemia
• QRS/QT abnormalities
• Ventricular dysrhythmias
• Seizures
• Cardiovascular collapse

Long-term hydroxychloroquine exposure can produce retinal toxicity, potentially causing:

• Paracentral visual defects
• Reduced visual acuity in advanced disease
• Altered color vision
• Progressive retinal damage

Chronic retinal toxicity differs from the cardiovascular emergency of acute overdose.

Digoxin and Cardiac Glycosides

Digoxin toxicity can produce characteristic disturbances in visual perception.

Possible complaints include:

• Blurred vision
• Photophobia
• Halos
• Altered color perception
• Yellow or yellow-green vision

These findings may accompany:

• Nausea/vomiting
• Confusion
• Bradycardia
• AV block
• Other dysrhythmias

Visual symptoms support the diagnosis but are not required for digoxin toxicity.

Anticholinergic Agents

Antimuscarinic drugs may cause blurred vision through:

• Marked mydriasis
• Cycloplegia
• Loss of accommodation

Patients may have difficulty focusing on near objects.

Associated findings include:

• Tachycardia
• Dry mouth
• Dry, flushed skin
• Reduced bowel sounds
• Urinary retention
• Agitation or delirium

Topical ophthalmic anticholinergics can produce particularly prominent ocular findings.

Botulism

Botulism causes presynaptic inhibition of acetylcholine release.

Early neurologic manifestations frequently involve the cranial nerves.

Visual complaints can include:

• Blurred vision
• Diplopia
• Difficulty focusing
• Ptosis

These may be followed by:

• Dysarthria
• Dysphagia
• Facial weakness
• Descending symmetric paralysis
• Respiratory failure

The patient is generally alert unless another process is present.

Ethambutol

Chronic ethambutol exposure can cause optic neuropathy.

Possible manifestations include:

• Reduced visual acuity
• Central visual defects
• Impaired color discrimination
• Bilateral visual symptoms

Early recognition and medication review are important because recovery is more likely when toxicity is recognized promptly.

Deferoxamine

Prolonged or excessive exposure can occasionally produce ocular toxicity, including:

• Reduced visual acuity
• Visual-field abnormalities
• Altered color perception
• Retinal or optic-nerve dysfunction

Visual abnormalities may improve after appropriate modification of therapy.

Mercury

Significant chronic mercury exposure can cause neurologic and visual abnormalities.

Possible manifestations include:

• Visual-field constriction
• Tremor
• Paresthesias
• Ataxia
• Neurobehavioral changes

The exact clinical pattern depends on the chemical form and exposure route.

Thallium

Thallium poisoning primarily produces gastrointestinal and neurologic toxicity but may occasionally affect the visual system.

Other clues include:

• Painful peripheral neuropathy
• Weakness
• Gastrointestinal symptoms
• Delayed alopecia

Vitamin A Toxicity

Excess vitamin A can increase intracranial pressure.

Possible findings include:

• Headache
• Nausea
• Diplopia
• Papilledema
• Visual disturbance

Chronic toxicity may also produce skin and hepatic abnormalities.

Chemical Eye Injury

Direct exposure to corrosive substances can damage:

• Conjunctiva
• Corneal epithelium
• Corneal stroma
• Anterior chamber
• Deeper ocular structures

Important exposures include:

• Strong alkalis
• Strong acids
• Phenolic chemicals
• Other corrosive agents

Symptoms may include:

• Severe pain
• Blepharospasm
• Tearing
• Redness
• Photophobia
• Blurred vision
• Corneal clouding

Alkali Versus Acid Injury

Alkali injuries are often particularly dangerous because they can penetrate deeply and continue damaging ocular tissue.

Severe alkali exposure may cause:

• Corneal opacification
• Limbal ischemia
• Anterior-segment injury
• Scarring
• Permanent visual impairment

Acids often cause more superficial coagulation injury, although concentrated acids can also cause severe ocular damage.

Important Principle: Pain Does Not Equal Severity

A painless eye after chemical exposure is not necessarily reassuring.

Severe chemical injury can damage sensory nerve endings and reduce pain despite extensive tissue injury.

Irritant Eye Exposures

Lacrimators and irritant chemicals may cause:

• Burning
• Tearing
• Conjunctival redness
• Blepharospasm
• Temporary blurred vision

Examples include:

• Pepper spray
• Tear gas
• Chlorine
• Other irritant gases or aerosols

Most uncomplicated irritant exposures improve after effective decontamination, but persistent symptoms require examination for corneal injury.

Immediate Management of Chemical Eye Exposure

The priority is:

Begin irrigation immediately.

Do not delay irrigation while trying to identify the exact chemical.

General principles include:

• Remove contact lenses when possible.
• Irrigate copiously with available clean fluid.
• Ensure the eyelids and conjunctival spaces are adequately exposed.
• Remove retained particulate material when appropriate.
• Check ocular pH in significant acid/alkali exposures.
• Continue irrigation until pH remains near physiologic range.

The clinical endpoint and normalization of ocular pH are more important than an arbitrary fixed irrigation volume.

Eye Examination

Assessment should include:

• Visual acuity in each eye
• Pupil size and reactivity
• Extraocular movements
• Visual fields when possible
• Eyelid and conjunctival examination
• Corneal clarity
• Fluorescein examination
• Slit-lamp examination when available

Intraocular pressure should be measured when glaucoma or other pressure-related pathology is suspected and when doing so is safe.

Fluorescein Examination

Fluorescein helps identify:

• Corneal epithelial defects
• Abrasions
• Ulceration
• Chemical injury

Significant chemical burns generally require ophthalmologic assessment.

Nontoxicologic Differential Diagnosis

Do not attribute acute visual loss automatically to poisoning.

Important alternatives include:

• Central retinal artery occlusion
• Retinal detachment
• Vitreous or retinal hemorrhage
• Acute angle-closure glaucoma
• Optic neuritis
• Ischemic optic neuropathy
• Stroke
• Intracranial hemorrhage
• Migraine
• Orbital disease
• Giant cell arteritis in the appropriate age group
• Raised intracranial pressure

Sudden painless monocular visual loss is particularly concerning for a retinal or vascular emergency.

Key Diagnostic Tests

Depending on the presentation, consider:

• Visual acuity testing
• Slit-lamp/fluorescein examination
• Ocular pH after chemical exposure
• Electrolytes and bicarbonate
• Anion gap
• Blood gas
• Serum osmolality/osmolal gap
• Methanol concentration
• ECG
• Digoxin concentration when indicated

Additional ophthalmologic or neurologic testing depends on the suspected cause.

Disposition

Systemic poisoning with visual abnormalities often requires admission or prolonged monitored treatment.

Chemical eye injuries require ophthalmologic follow-up, with urgent specialist evaluation for:

• Reduced visual acuity
• Significant epithelial injury
• Corneal clouding
• Limbal ischemia
• Persistent abnormal pH
• Severe pain
• Suspected penetrating injury

Key Points

• Visual toxicity may arise from corneal injury, retinal injury, optic neuropathy, neurologic dysfunction, or altered accommodation.
• Methanol + visual symptoms + high-anion-gap metabolic acidosis is a major toxicologic emergency.
• A normal osmolal gap does not exclude late methanol poisoning.
• Fomepizole is preferred for inhibiting methanol metabolism; severe cases may require dialysis.
• Quinine can produce tinnitus together with severe visual disturbance.
• Digoxin may cause halos and altered yellow-green color perception.
• Anticholinergics commonly blur vision through mydriasis and cycloplegia.
• Botulism can begin with diplopia, blurred vision, ptosis, and bulbar weakness.
• Chronic ethambutol exposure can produce optic neuropathy and impaired color vision.
• Chemical eye exposure requires immediate irrigation.
• Severe alkali burns may penetrate deeply and threaten vision.
• Lack of pain does not exclude severe ocular injury.
• Sudden visual loss always requires consideration of nontoxic ophthalmologic and neurologic emergencies.

187. Toxicology – Withdrawal Syndromes

Core Concept

Withdrawal occurs when a person who has developed physiologic adaptation to a substance experiences symptoms after:

• Abrupt cessation
• Rapid dose reduction
• Falling drug concentrations
• Administration of an antagonist
• Administration of certain partial agonists in susceptible opioid-dependent patients

Withdrawal syndromes differ substantially according to the drug class.

The most important distinction is:

Alcohol and sedative-hypnotic withdrawal can be life-threatening.

Typical opioid and stimulant withdrawal are usually not directly life-threatening in otherwise healthy adults, although complications and coexisting illness can still be serious.

General Principle

Withdrawal often produces physiologic effects roughly opposite to those produced during intoxication.

Examples:

CNS depressant intoxication → sedation

CNS depressant withdrawal → CNS hyperactivity

Similarly:

Opioid intoxication → miosis, reduced GI activity, CNS/respiratory depression

Opioid withdrawal → mydriasis, diarrhea, autonomic activation

This is useful conceptually but should not replace clinical assessment.

Alcohol Withdrawal

Chronic alcohol exposure causes neuroadaptation involving:

• Reduced inhibitory GABAergic function
• Increased excitatory glutamatergic activity

When alcohol concentrations fall abruptly, this adapted nervous system becomes excessively excitable.

Clinical severity ranges from mild tremulousness to seizures and delirium.

Early Alcohol Withdrawal

Possible findings include:

• Anxiety
• Tremor
• Insomnia
• Nausea
• Diaphoresis
• Tachycardia
• Hypertension
• Headache
• Agitation

Importantly:

Withdrawal can begin while measurable alcohol remains in the blood.

A rapid decline from a chronically high concentration may be sufficient to trigger symptoms.

Alcohol Withdrawal Seizures

Withdrawal can cause generalized seizures.

They often occur relatively early in the withdrawal course.

Important alternative causes should still be considered, including:

• Hypoglycemia
• Hyponatremia
• Head trauma
• Intracranial hemorrhage
• Infection
• Coingestion
• Primary epilepsy

Repeated or atypical seizures require broader investigation.

Alcohol Withdrawal Delirium

The most severe alcohol withdrawal syndrome is alcohol withdrawal delirium, historically called delirium tremens.

Features include:

• Severe agitation
• Confusion
• Disorientation
• Hallucinations
• Tremor
• Marked autonomic hyperactivity
• Tachycardia
• Hypertension
• Diaphoresis
• Hyperthermia

Complications can include:

• Dehydration
• Electrolyte abnormalities
• Rhabdomyolysis
• Dysrhythmias
• Aspiration
• Cardiovascular collapse

This is a medical emergency.

Sedative-Hypnotic Withdrawal

Withdrawal from GABAergic sedative medications can resemble alcohol withdrawal.

Important substances include:

• Benzodiazepines
• Barbiturates
• Certain older sedative-hypnotics

Possible manifestations include:

• Anxiety
• Tremor
• Insomnia
• Agitation
• Tachycardia
• Hypertension
• Perceptual disturbances
• Delirium
• Seizures

Severe withdrawal can be fatal.

Benzodiazepine Withdrawal

Withdrawal risk depends on:

• Duration of use
• Dose
• Degree of physiologic dependence
• Drug half-life
• Speed of discontinuation

Shorter-acting agents may produce earlier symptoms, while withdrawal from long-acting agents may be delayed.

Abrupt discontinuation after substantial chronic exposure can cause seizures or severe autonomic instability.

GHB Withdrawal

Chronic heavy gamma-hydroxybutyrate use can produce a particularly severe withdrawal syndrome.

Possible findings include:

• Severe agitation
• Insomnia
• Tremor
• Tachycardia
• Hypertension
• Hallucinations
• Delirium

The syndrome can progress rapidly and may require intensive management.

Alcohol/Sedative Withdrawal Differential Diagnosis

Conditions that can resemble severe withdrawal include:

• Sympathomimetic poisoning
• Anticholinergic toxicity
• Serotonin syndrome
• Neuroleptic malignant syndrome
• MAOI toxicity
• Hyperthyroidism
• Sepsis
• Heat stroke
• Intracranial hemorrhage
• CNS infection
• Primary psychiatric disease

Do not automatically attribute agitation and tachycardia to withdrawal simply because a patient has a history of substance use.

Treatment of Alcohol Withdrawal

Benzodiazepines are first-line therapy.

Treatment aims to control:

• Agitation
• Tremor
• Autonomic hyperactivity
• Seizures
• Progression to severe withdrawal

Medication should be titrated according to clinical severity and monitoring.

Phenobarbital is also used in selected patients and protocols, particularly for severe or difficult-to-control withdrawal.

Thiamine and Supportive Care

Patients with chronic heavy alcohol use may have thiamine deficiency.

Thiamine should be provided when clinically indicated, particularly when malnutrition or Wernicke encephalopathy is a concern.

Also assess and correct:

• Hypoglycemia
• Dehydration
• Potassium abnormalities
• Magnesium abnormalities
• Other nutritional deficiencies

Urgent glucose treatment should not be delayed in a hypoglycemic patient while waiting to administer thiamine.

Withdrawal Seizure Treatment

Benzodiazepines are central to treatment of alcohol or sedative-hypnotic withdrawal seizures.

Phenytoin is generally ineffective for preventing recurrent seizures caused purely by alcohol withdrawal because it does not correct the underlying withdrawal physiology.

It may still be appropriate when the patient has a separate seizure disorder requiring it.

Opioid Withdrawal

Opioid withdrawal results from loss of opioid receptor stimulation after physiologic dependence has developed.

It may follow:

• Abrupt opioid discontinuation
• Major dose reduction
• Naloxone administration
• Inappropriately timed partial-agonist therapy

Clinical Features of Opioid Withdrawal

Typical findings include:

• Anxiety
• Restlessness
• Yawning
• Lacrimation
• Rhinorrhea
• Mydriasis
• Piloerection
• Diaphoresis
• Myalgias
• Abdominal cramping
• Nausea/vomiting
• Diarrhea
• Increased bowel sounds
• Tachycardia

Patients may feel extremely unwell despite the syndrome usually not being directly fatal in otherwise healthy adults.

Complications of Opioid Withdrawal

Severe vomiting and diarrhea may cause:

• Dehydration
• Electrolyte disturbances
• Acute kidney injury

Risk can be greater in:

• Frail patients
• Pregnant patients
• Patients with major comorbidities
• Neonates

Return to opioid use after loss of tolerance also increases subsequent overdose risk.

Opioid Withdrawal Treatment

Modern treatment generally favors opioid agonist therapy when appropriate.

Important options include:

• Buprenorphine
• Methadone

These can relieve withdrawal and support ongoing treatment of opioid use disorder.

Non-opioid medications such as:

• Clonidine
• Lofexidine

may reduce autonomic symptoms but generally do not treat opioid use disorder itself.

Additional symptomatic treatment may address:

• Nausea
• Diarrhea
• Pain
• Dehydration

Precipitated Opioid Withdrawal

An opioid antagonist can rapidly displace opioid agonists and produce abrupt withdrawal.

Similarly, initiating buprenorphine at an inappropriate point after certain opioid exposures can precipitate withdrawal because of its high receptor affinity and partial agonist activity.

This syndrome can be much more abrupt than spontaneous withdrawal.

Stimulant Withdrawal

Withdrawal can occur after cessation of chronic use of:

• Cocaine
• Amphetamines
• Methamphetamine
• Other stimulants

The syndrome differs substantially from alcohol withdrawal.

Stimulant Withdrawal Features

Typical symptoms include:

• Fatigue
• Increased sleep
• Dysphoria
• Depressed mood
• Irritability
• Reduced motivation
• Poor concentration
• Increased appetite
• Drug craving

Some patients experience marked psychomotor slowing.

Unlike severe alcohol or sedative withdrawal, stimulant withdrawal generally does not cause the same autonomic hyperexcitable seizure syndrome.

Mental Health Risk in Stimulant Withdrawal

Although the physical withdrawal syndrome is usually not directly life-threatening, severe depression may occur.

Assessment should include:

• Suicidal thoughts
• Severe depression
• Psychosis
• Ability to care for oneself
• Coexisting substance use

Psychiatric risk may therefore be more important than physiologic instability.

Nicotine and Caffeine Withdrawal

These generally produce milder syndromes.

Nicotine withdrawal

May cause:

• Irritability
• Anxiety
• Difficulty concentrating
• Increased appetite
• Restlessness
• Craving

Caffeine withdrawal

May cause:

• Headache
• Fatigue
• Sleepiness
• Reduced concentration
• Irritability

These syndromes are generally self-limited.

Neonatal Withdrawal

Neonates exposed chronically to certain substances before birth may develop withdrawal after delivery.

Modern terminology for opioid-related neonatal withdrawal includes neonatal opioid withdrawal syndrome (NOWS).

Manifestations may include:

• Irritability
• Tremor
• Abnormal sleep
• Feeding difficulty
• Gastrointestinal symptoms
• Autonomic abnormalities

Management is specialized and differs from adult withdrawal care.

The older source’s recommendation of paregoric as the drug of choice is obsolete and should not be carried into modern study notes.

Diagnostic Evaluation

Withdrawal is primarily a clinical diagnosis supported by exposure history.

Important questions include:

• Substance used
• Duration of use
• Typical amount
• Last use
• Recent dose reduction
• Formulation/half-life
• Other substances
• Previous severe withdrawal
• Previous withdrawal seizures
• Medical comorbidities

Laboratory Evaluation

Testing should be guided by severity.

Potential studies include:

• Bedside glucose
• Electrolytes
• Magnesium
• Renal function
• Liver tests
• CBC
• CK when severe agitation, seizures, or hyperthermia occur

Additional testing may be necessary when altered mental status or seizures have an uncertain cause.

When to Consider Brain Imaging or Other Workup

Withdrawal should not be assumed to explain every neurologic abnormality.

Consider further investigation when there is:

• Head trauma
• Focal neurologic deficit
• Unusual seizure pattern
• Persistent altered mental status
• Fever or meningismus
• Concern for intracranial hemorrhage
• Clinical suspicion of infection

Decontamination

Gastrointestinal decontamination has no routine role in withdrawal because withdrawal results from declining drug exposure rather than an ongoing ingestion.

An exception would be a separate acute ingestion occurring at the same time.

Monitoring

Patients with severe alcohol or sedative-hypnotic withdrawal require monitoring for:

• Mental status
• Agitation
• Seizures
• Respiratory status during sedative therapy
• Heart rate
• Blood pressure
• Temperature
• Hydration
• Electrolytes

Severe withdrawal may require ICU-level management.

Timing of Withdrawal

The onset and duration depend heavily on the substance’s pharmacokinetics.

General principle:

Shorter-acting drug → earlier withdrawal

Longer-acting drug → potentially delayed withdrawal

Therefore, fixed timelines should not be applied rigidly.

Important Pitfalls

• Withdrawal does not require complete abstinence; a substantial fall in drug concentration may trigger it.
• Alcohol withdrawal can begin despite a measurable blood alcohol concentration.
• Long-acting sedative withdrawal may be delayed.
• Do not mistake stimulant intoxication for alcohol withdrawal.
• Do not mistake opioid intoxication for stimulant withdrawal-related sleepiness.
• Phenytoin does not correct the underlying mechanism of uncomplicated alcohol-withdrawal seizures.
• Beta-blockers, clonidine, and antipsychotics may sometimes be adjuncts but do not replace adequate GABAergic treatment for severe alcohol withdrawal.
• Severe agitation should not automatically be attributed to withdrawal; infection, intracranial disease, metabolic disorders, and poisoning must remain in the differential.
• Avoid dismissing reported withdrawal as drug-seeking behavior; assess the syndrome objectively and treat clinically significant findings.

Key Points

• Withdrawal follows cessation, dose reduction, or antagonism after physiologic adaptation.
• Alcohol and sedative-hypnotic withdrawal can cause seizures, delirium, hyperthermia, and death.
• Benzodiazepines are first-line treatment for clinically significant alcohol withdrawal.
• Phenobarbital has an important role in selected severe alcohol/sedative withdrawal protocols.
• Phenytoin is generally ineffective for uncomplicated alcohol-withdrawal seizures.
• Withdrawal can begin while blood alcohol remains measurable.
• Opioid withdrawal typically causes mydriasis, yawning, lacrimation, rhinorrhea, piloerection, myalgias, vomiting, and diarrhea.
• Typical adult opioid withdrawal is usually not directly life-threatening, but dehydration and other complications can occur.
• Buprenorphine or methadone are important modern treatments for opioid withdrawal and opioid use disorder.
• Clonidine or lofexidine can reduce autonomic opioid-withdrawal symptoms.
• Stimulant withdrawal mainly causes fatigue, hypersomnia, dysphoria, depression, and craving.
• Suicide risk and severe depression should be assessed during stimulant withdrawal.
• Long-acting drugs may produce delayed withdrawal, so onset cannot be predicted from a single universal timeline.
• Treatment should address the specific withdrawal syndrome and its complications, while continuing to consider alternative diagnoses.

Toxicology – Ventricular Dysrhythmias

Core Concept

Toxicologic ventricular dysrhythmias are abnormal rhythms or conduction disturbances involving the ventricles that result from exposure to a drug, chemical, or toxin.

They range from:

• Premature ventricular complexes
• Wide-complex tachycardia
• Monomorphic or polymorphic ventricular tachycardia
• Torsades de pointes
• Ventricular fibrillation
• Severe intraventricular conduction delay

In poisoning, treatment should address both the rhythm and the toxicologic mechanism producing it.

Major Mechanisms

Toxins can provoke ventricular dysrhythmias through several pathways.

1. Sodium-Channel Blockade

Fast sodium-channel inhibition slows ventricular depolarization.

This produces:

Slowed conduction → QRS widening → ventricular dysrhythmia

Important causes include:

• Tricyclic antidepressants
• Certain first-generation antihistamines
• Class I antiarrhythmics
• Carbamazepine in severe poisoning
• Some antipsychotics
• Other membrane-stabilizing drugs

Severe sodium-channel blockade may also cause:

• Hypotension
• Seizures
• Coma

2. Potassium-Channel Effects and QT Prolongation

Delayed ventricular repolarization can prolong the QT interval.

Excessive QT prolongation increases susceptibility to torsades de pointes, a polymorphic ventricular tachycardia.

Risk is increased by:

• Hypokalemia
• Hypomagnesemia
• Bradycardia
• Multiple QT-prolonging drugs
• Congenital long-QT syndromes

3. Myocardial Ischemia

Toxicant-associated myocardial ischemia may result from:

• Coronary vasospasm
• Severe hypertension
• Hypotension
• Increased myocardial oxygen demand
• Reduced oxygen delivery

Cocaine and other sympathomimetics are important examples.

Ischemic myocardium is electrically unstable and may develop ventricular dysrhythmias.

4. Hypoxia and Impaired Oxygen Delivery

Ventricular dysrhythmias may occur secondary to:

• Severe hypoventilation
• Pulmonary injury
• Carbon monoxide poisoning
• Methemoglobinemia
• Cyanide toxicity
• Profound shock

Correcting oxygenation and ventilation is therefore part of dysrhythmia management.

5. Electrolyte Disturbances

Important abnormalities include:

• Hyperkalemia
• Hypokalemia
• Hypomagnesemia
• Hypocalcemia

These may directly alter cardiac conduction or increase susceptibility to drug-induced dysrhythmias.

6. Direct Cardiac Toxicity

Certain poisons directly disturb:

• Automaticity
• AV conduction
• Myocardial contractility
• Intracellular calcium handling
• Ion-channel function

Examples include:

• Digoxin
• Beta-blockers
• Calcium channel blockers
• Chloroquine/hydroxychloroquine
• Certain antiarrhythmics

Risk Factors

Severe ventricular dysrhythmias are more likely in patients with:

• Pre-existing structural heart disease
• Coronary artery disease
• Baseline conduction abnormalities
• Congenital long-QT syndrome
• Electrolyte disturbances
• Hypoxia
• Severe acidemia
• Large or mixed overdose
• Multiple QT-prolonging medications

Important Toxicologic Causes

Tricyclic Antidepressants

TCAs produce cardiotoxicity primarily through fast sodium-channel blockade, with additional autonomic and myocardial effects.

Typical findings include:

• Sinus tachycardia
• QRS widening
• Hypotension
• Altered mental status
• Seizures
• Ventricular dysrhythmias

A terminal R wave in lead aVR may support sodium-channel blockade, but it is not specific for TCA poisoning.

Increasing QRS duration generally indicates increasing sodium-channel toxicity.

Sodium bicarbonate is the key treatment for clinically significant TCA-associated sodium-channel blockade.

First-Generation Antihistamines

Certain antihistamines, particularly in severe overdose, can produce both:

• Anticholinergic toxicity
• Sodium-channel blockade

Possible findings include:

• Tachycardia
• Mydriasis
• Dry skin and mucosa
• Delirium
• Seizures
• QRS widening
• QT prolongation
• Ventricular dysrhythmias

Diphenhydramine is an important example.

Class I Antiarrhythmics

These medications can paradoxically produce serious dysrhythmias in overdose.

Depending on the specific agent, effects may include:

• QRS widening
• QT prolongation
• Hypotension
• Ventricular tachycardia
• Torsades de pointes

Adding another sodium-channel-blocking antiarrhythmic may worsen toxicity.

Cocaine and Other Sympathomimetics

Stimulants can produce ventricular dysrhythmias through:

• Catecholamine excess
• Increased myocardial oxygen demand
• Coronary vasoconstriction
• Hyperthermia
• Ischemia
• Acidosis

Cocaine additionally has sodium-channel-blocking properties.

Associated findings include:

• Agitation
• Tachycardia
• Hypertension
• Diaphoresis
• Mydriasis
• Hyperthermia
• Seizures
• Rhabdomyolysis

Theophylline

Theophylline toxicity can cause:

• Marked sinus tachycardia
• Supraventricular dysrhythmias
• Ventricular ectopy
• Ventricular dysrhythmias in severe poisoning

Associated clues include:

• Tremor
• Recurrent vomiting
• Hypokalemia
• Hyperglycemia
• Seizures

Severe theophylline poisoning may require extracorporeal removal.

Digoxin

Digoxin toxicity can produce an unusually broad range of dysrhythmias because it affects both:

• Automaticity
• AV nodal conduction

Possible rhythms include:

• Premature ventricular complexes
• AV block
• Junctional rhythms
• Atrial tachycardia with AV block
• Bidirectional ventricular tachycardia
• Ventricular tachycardia/fibrillation

Associated findings may include:

• Nausea/vomiting
• Confusion
• Visual abnormalities
• Bradycardia
• Hyperkalemia in significant acute poisoning

Bidirectional ventricular tachycardia is an important clue to digoxin toxicity, although it is not completely specific.

Clinically important digoxin toxicity is treated with digoxin immune Fab.

Chloroquine and Hydroxychloroquine

Severe poisoning can rapidly produce:

• Hypotension
• Hypokalemia
• QRS widening
• QT prolongation
• Ventricular dysrhythmias
• Cardiovascular collapse

The combination of profound hypotension, conduction abnormalities, and hypokalemia after a compatible exposure is particularly concerning.

Carbamazepine

Large overdoses may produce:

• CNS depression
• Ataxia
• Nystagmus
• Seizures
• QRS widening
• Ventricular dysrhythmias

Severe cardiotoxicity can resemble other sodium-channel-blocking poisonings.

Organophosphates and Carbamates

Cholinergic poisoning can produce variable cardiac effects.

Possible rhythms include:

• Sinus tachycardia
• Bradycardia
• AV conduction abnormalities
• Ventricular dysrhythmias

Associated findings include:

• Miosis
• Salivation
• Bronchorrhea
• Vomiting
• Diarrhea
• Sweating
• Fasciculations
• Weakness

Heart rate alone cannot reliably identify or exclude a cholinergic syndrome.

Thyroid Hormone

Excess thyroid hormone usually produces:

• Sinus tachycardia
• Supraventricular tachyarrhythmias
• Atrial fibrillation

Ventricular dysrhythmias are less common but may occur in severe thyrotoxicosis, particularly when underlying cardiac disease is present.

Nontoxicologic Differential Diagnosis

Always consider causes unrelated to poisoning, including:

• Acute coronary syndrome
• Myocarditis
• Structural heart disease
• Congenital arrhythmia syndromes
• Intracranial catastrophe
• Hypoglycemia
• Severe hypoxia
• Electrolyte abnormalities
• Acid-base disturbances

A toxic exposure and a primary cardiac disorder may coexist.

Clinical Presentation

Patients may report:

• Palpitations
• Chest discomfort
• Dyspnea
• Weakness
• Dizziness
• Lightheadedness
• Presyncope

Severe ventricular dysrhythmias can cause:

• Syncope
• Hypotension
• Seizure-like activity from cerebral hypoperfusion
• Cardiogenic shock
• Cardiac arrest

In a poisoning patient, sudden syncope should raise concern for a significant dysrhythmia.

Clinical Clues to the Cause

Wide QRS + Seizures + Hypotension

Strongly consider:

• TCA poisoning
• Other sodium-channel blockers

Wide QRS + Anticholinergic Findings

Consider:

• TCA
• Diphenhydramine or another cardiotoxic antihistamine
• Other antimuscarinic drugs with sodium-channel effects

Ventricular Dysrhythmia + Severe Agitation/Hyperthermia

Consider:

• Cocaine
• Amphetamines
• Other sympathomimetics

Dysrhythmia + Vomiting + Tremor + Hypokalemia

Consider:

Theophylline toxicity

Dysrhythmia + AV Block

Consider:

• Digoxin
• Beta-blockers
• Calcium channel blockers
• Other conduction-suppressing drugs

Dysrhythmia + Hyperkalemia

Consider:

• Significant acute digoxin toxicity
• Severe renal failure
• Potassium poisoning
• Severe acidosis/tissue injury

Hyperkalemia itself can produce progressive conduction abnormalities and malignant dysrhythmias.

Dysrhythmia + Hypokalemia

Consider:

• Theophylline
• β₂-agonists
• Chloroquine/hydroxychloroquine

Hypokalemia also increases susceptibility to QT-related dysrhythmias.

ECG Evaluation

Obtain a 12-lead ECG and institute continuous cardiac monitoring in clinically important toxicologic dysrhythmias.

Evaluate:

• Rhythm
• Rate
• PR interval
• QRS duration
• QT/QTc
• AV conduction
• Ventricular ectopy
• Ischemic changes

Serial ECGs are useful because conduction abnormalities can evolve as absorption and toxicity progress.

QRS Widening

A widened QRS in poisoning should prompt consideration of sodium-channel blockade.

Potential causes include:

• TCAs
• Certain antihistamines
• Class I antiarrhythmics
• Carbamazepine
• Cocaine
• Other sodium-channel blockers

Treatment should be based on the overall evidence of clinically important sodium-channel toxicity, rather than relying on one rigid QRS threshold.

QT Prolongation

QT prolongation indicates delayed ventricular repolarization and may predispose to torsades de pointes.

Assess for:

• QT-prolonging drugs
• Hypokalemia
• Hypomagnesemia
• Hypocalcemia
• Bradycardia

Serial ECG monitoring is important when QT prolongation is substantial or evolving.

Laboratory Evaluation

Useful investigations may include:

• Bedside glucose
• Sodium
• Potassium
• Calcium
• Magnesium
• Bicarbonate
• BUN/creatinine
• Blood gas when clinically indicated
• Lactate

Targeted toxicant concentrations may include:

• Digoxin
• Theophylline
• Salicylate
• Other measurable drugs when clinically relevant

Acetaminophen testing should be considered in significant intentional or unknown ingestions because early toxicity may be clinically silent.

Broad urine drug screening has limited ability to establish the cause of a dysrhythmia.

Initial Management

The first priorities are:

Airway → breathing → circulation → rhythm assessment → identify and reverse the toxicologic mechanism

Immediately address:

• Hypoxemia
• Inadequate ventilation
• Severe acid-base disturbance
• Electrolyte abnormalities
• Hyperthermia
• Hypoglycemia
• Shock

Unstable ventricular rhythms should be managed using appropriate resuscitation principles while toxin-specific treatment is initiated.

Sodium-Channel Blocker Cardiotoxicity

Sodium bicarbonate is the major therapy for significant poisoning characterized by sodium-channel blockade.

Clinical indications can include:

• Significant QRS widening
• Ventricular dysrhythmia attributable to sodium-channel blockade
• Hypotension associated with this mechanism

Therapy requires monitoring of:

• ECG response
• Blood pH
• Sodium
• Potassium

Excessive alkalemia and electrolyte abnormalities should be avoided.

Ventricular Tachycardia

Management depends on:

• Hemodynamic stability
• QRS morphology
• QT interval
• Suspected toxicant
• Underlying mechanism

An unstable patient with ventricular tachycardia requires immediate resuscitative rhythm management.

In toxicology, conventional antiarrhythmic selection must be made carefully because some drugs can worsen the underlying channel disturbance.

For example, adding another sodium-channel blocker to severe sodium-channel-blocker poisoning can aggravate conduction delay.

Torsades de Pointes

Torsades is a polymorphic ventricular tachycardia associated with prolonged ventricular repolarization.

Management includes:

• Stop QT-prolonging agents.
• Correct hypokalemia.
• Correct hypomagnesemia.
• Treat other contributing electrolyte abnormalities.
• Give IV magnesium when torsades occurs.
• Use electrical therapy if the patient is unstable or pulseless.

For recurrent pause-dependent torsades, increasing the heart rate with overdrive pacing may be considered in selected cases.

Additional QT-prolonging antiarrhythmics should generally be avoided.

Digoxin-Associated Dysrhythmias

The most important treatment for severe digoxin-associated cardiac toxicity is:

Digoxin immune Fab

This should be considered particularly when significant poisoning produces:

• Life-threatening ventricular dysrhythmias
• Severe bradydysrhythmias
• Clinically important hyperkalemia in acute toxicity
• Other evidence of severe digoxin poisoning

After Fab administration, routine total serum digoxin measurements can become misleading because assays detect both bound and unbound digoxin.

Electrolyte Correction

Correct clinically important abnormalities promptly.

Potassium

Both high and low potassium can cause or worsen dysrhythmias.

Magnesium

Deficiency increases susceptibility to torsades and other ventricular dysrhythmias.

Calcium

Marked abnormalities can alter cardiac conduction and repolarization.

The goal is to correct the physiologic abnormality while simultaneously treating its toxicologic cause.

Hypotension and Shock

Ventricular dysrhythmia may both cause and result from shock.

Assess for:

• Hypovolemia
• Vasodilation
• Myocardial depression
• Severe bradycardia/conduction block
• Persistent ventricular dysrhythmia

Management may require:

• Careful fluid resuscitation
• Vasopressors
• Poison-specific cardiovascular therapy
• Electrical therapy
• Advanced circulatory support in selected refractory poisonings

Routine large fluid volumes should not be given without considering myocardial function and the mechanism of shock.

Bradyarrhythmias in Poisoning

Although this topic focuses on ventricular dysrhythmias, severe poisoning may produce bradycardia or conduction block.

Important causes include:

• Beta-blockers
• Calcium channel blockers
• Digoxin
• Cholinergic agents
• Clonidine/imidazolines

Standard ACLS measures may be insufficient because the underlying toxic mechanism persists.

Management therefore emphasizes toxin-specific cardiovascular therapy, with pacing used when appropriate.

Decontamination

Do not induce vomiting.

Routine gastric lavage is generally not recommended.

Activated charcoal may be considered for a selected recent, serious, adsorbable ingestion when:

• The airway is adequately protected.
• Aspiration risk is acceptable.
• No major contraindication exists.
• Administration will not delay cardiovascular stabilization.

A patient with ventricular dysrhythmia, seizures, or altered consciousness should be stabilized before gastrointestinal decontamination is considered.

Monitoring and Disposition

A new clinically significant ventricular dysrhythmia associated with poisoning generally requires a high-acuity monitored setting.

Monitor:

• Continuous ECG
• Blood pressure
• Oxygenation
• Ventilation
• Mental status
• Temperature
• Electrolytes
• Acid-base status

Serial ECGs and toxicant-specific laboratory testing may be necessary.

Patients with severe cardiotoxic poisoning may require intensive care.

Important Modernization of the Older Source

Several elements of the source reflect older toxicology practice.

Current management generally avoids:

• Routine gastric lavage
• Routine treatment based solely on one fixed QRS cutoff
• Automatic use of lidocaine for every ventricular ectopic rhythm
• Routine phenytoin/fosphenytoin as therapy for toxicologic ventricular dysrhythmias
• Bretylium, which has essentially disappeared from modern routine practice
• Routine Trendelenburg positioning for hypotension
• Large empiric fluid administration without assessment of the shock mechanism

Modern treatment emphasizes mechanism-directed therapy, ECG interpretation, electrolyte correction, appropriate electrical therapy, and toxin-specific antidotes.

Key Points

• Toxicologic ventricular dysrhythmias can result from ion-channel blockade, myocardial ischemia, hypoxia, electrolyte abnormalities, or direct myocardial toxicity.
• Sodium-channel blockade typically causes progressive QRS widening and may lead to hypotension, seizures, and ventricular dysrhythmias.
• Important sodium-channel-blocking poisons include TCAs, certain antihistamines, class I antiarrhythmics, carbamazepine, and cocaine.
• Sodium bicarbonate is central to treatment of clinically important toxicologic sodium-channel blockade.
• QT prolongation increases susceptibility to torsades de pointes, particularly with hypokalemia or hypomagnesemia.
• Torsades is treated with IV magnesium and correction of contributing factors, with electrical therapy for instability.
• Digoxin can produce almost any dysrhythmia; bidirectional ventricular tachycardia is an important clue.
• Severe digoxin-associated dysrhythmias are treated with digoxin immune Fab.
• Chloroquine/hydroxychloroquine poisoning can cause rapid cardiovascular collapse, QRS/QT abnormalities, ventricular dysrhythmias, and marked hypokalemia.
• Stimulants may cause dysrhythmias through catecholamine excess, ischemia, hyperthermia, and acidosis.
• Correct hypoxia, acid-base abnormalities, potassium, magnesium, and calcium disturbances when clinically important.
• Do not assume that a standard antiarrhythmic is safe merely because the rhythm resembles a conventional cardiac dysrhythmia; the toxicologic mechanism matters.
• Unstable ventricular tachycardia or ventricular fibrillation requires immediate resuscitative electrical management while the underlying poisoning is treated.
• Significant poison-induced ventricular dysrhythmias generally require continuous cardiac monitoring and high-acuity care.

Toxicology – Abnormal Urine Color

Core Concept

Urine can change color because of:

• Normal variation in concentration
• Drugs or their metabolites
• Foods and dyes
• Blood or muscle pigments
• Bile pigments
• Infection
• Metabolic disorders
• Renal or hepatic disease
• Certain toxic exposures

Normal yellow urine is largely related to urochrome pigments. Concentrated urine is generally darker, whereas dilute urine appears paler.

An unusual urine color is therefore a diagnostic clue rather than a diagnosis.

First Diagnostic Question: Is It Really Blood?

Red, reddish-brown, or dark urine should first be evaluated for:

• Hematuria – intact RBCs in urine
• Hemoglobinuria – free hemoglobin from intravascular hemolysis
• Myoglobinuria – myoglobin released from injured skeletal muscle
• Non-heme pigments from medications, foods, or metabolites

Modern urine dipsticks detect the peroxidase activity of heme, so both hemoglobin and myoglobin can produce a positive “blood” result.

A useful approach is:

Urine dipstick positive for blood + many RBCs on microscopy → hematuria

Urine dipstick positive for blood + few/no RBCs → consider hemoglobinuria or myoglobinuria

This corrects the older source description suggesting that myoglobin should produce a negative blood dipstick.

Bright or Fluorescent Yellow Urine

Important causes include:

• Riboflavin (vitamin B₂) – often produces striking fluorescent yellow urine
• Fluorescein dye
• Concentrated urine
• Some vitamin preparations

Yellow-to-amber urine may also occur with bile pigments, although bilirubinuria generally produces darker yellow-brown or tea-colored urine rather than simply bright yellow urine.

Orange Urine

Common causes include:

• Phenazopyridine
• Rifampin
• Dehydration/concentrated urine
• Certain vitamin supplements
• Carotenoid-rich foods
• Bilirubin

Phenazopyridine commonly produces vivid orange or reddish-orange urine.

Rifampin can discolor several body fluids, including:

• Urine
• Tears
• Sweat
• Saliva

This drug-related discoloration is usually expected rather than evidence of renal injury.

Red or Pink Urine

Red urine does not automatically mean hematuria.

Important categories include:

Blood-Related

• Hematuria
• Hemoglobinuria
• Myoglobinuria

Foods

• Beets
• Blackberries
• Certain food dyes

Medications

• Rifampin
• Phenazopyridine
• Doxorubicin
• Some phenothiazines
• Certain other drugs or metabolites

Metabolic Pigments

• Porphyrins

The urinalysis and clinical context usually distinguish these possibilities.

Hematuria

Hematuria means RBCs are present in the urine.

Possible causes include:

• Urinary tract disease
• Stones
• Trauma
• Infection
• Renal disease
• Anticoagulation-associated bleeding
• Coagulopathy

The urine dipstick is typically positive for blood, with RBCs visible on microscopy.

Hemoglobinuria

Hemoglobinuria occurs when intravascular hemolysis releases hemoglobin into plasma and ultimately urine.

Potential toxicologic causes include oxidant-induced hemolysis from selected chemicals or medications.

Typical pattern:

• Dark/red-brown urine
• Positive urine heme test
• Few or no RBCs on microscopy
• Evidence of hemolysis

Additional investigations may include:

• CBC
• Bilirubin
• LDH
• Haptoglobin
• Peripheral blood smear

Myoglobinuria

Myoglobinuria usually results from rhabdomyolysis.

Potential toxicologic triggers include:

• Stimulant poisoning
• Severe hyperthermia
• Prolonged seizures
• Serotonin syndrome
• Neuroleptic malignant syndrome
• Prolonged coma/immobility
• Severe muscle injury

Urine may appear:

• Red-brown
• Tea-colored
• Cola-colored

Typical laboratory pattern:

Positive urine dipstick for blood + few/no RBCs on microscopy + elevated CK → strongly suggests myoglobinuria from muscle injury

Myoglobinuria is clinically important because severe rhabdomyolysis can contribute to acute kidney injury and electrolyte disturbances.

Porphyrins

Porphyrin disorders can produce:

• Red urine
• Reddish-brown urine
• Purple-appearing urine

Some porphyrin-containing urine becomes darker after exposure to light or prolonged standing.

Acute porphyrias may also produce:

• Severe episodic abdominal pain
• Autonomic abnormalities
• Neurologic symptoms
• Psychiatric manifestations
• Hyponatremia

Urine color alone is insufficient to diagnose porphyria.

Purple Urine

Purple discoloration is unusual.

An important modern clinical entity is purple urine bag syndrome, usually occurring in catheterized patients when bacterial metabolism of tryptophan derivatives produces colored pigments that interact with the catheter tubing or collection bag.

Risk factors include:

• Long-term urinary catheterization
• Bacteriuria
• Constipation
• Alkaline urine
• Frailty or chronic illness

The dramatic color itself does not necessarily indicate severe systemic poisoning.

Certain medications, metabolites, or dyes can also produce purple-red discoloration.

Blue or Green Urine

Important medication- or dye-related causes include:

• Methylene blue
• Propofol
• Amitriptyline
• Indomethacin
• Certain diagnostic dyes
• Some drug metabolites

Methylene blue may cause blue-green urine after therapeutic use.

Propofol infusion can occasionally cause green urine through phenolic metabolites; this discoloration is generally benign by itself.

Green Urine and Infection

Greenish urine may occasionally occur with Pseudomonas urinary infection, although urine color alone is neither sensitive nor specific enough to diagnose it.

When infection is suspected, assess:

• Urinalysis
• Microscopy
• Urine culture when indicated
• Clinical signs of urinary or systemic infection

Bile Pigments and Green Urine

Biliverdin and related bile pigments can occasionally produce greenish discoloration.

Associated findings may suggest hepatobiliary disease:

• Jaundice
• Elevated bilirubin
• Abnormal liver tests
• Evidence of biliary obstruction

Brown or Tea-Colored Urine

Important causes include:

• Myoglobin
• Hemoglobin
• Bilirubin
• Metronidazole
• Nitrofurantoin
• Certain antimalarials
• Some laxative metabolites
• Levodopa-related metabolites
• Phenolic compounds
• Porphyrins

Dark urine should therefore trigger consideration of both benign medication discoloration and serious systemic disease.

Bilirubinuria

Conjugated bilirubin is water-soluble and can enter the urine.

Dark yellow-brown or tea-colored urine may therefore occur with:

• Cholestasis
• Biliary obstruction
• Hepatocellular disease causing conjugated hyperbilirubinemia

A key correction to the older source is:

Unconjugated bilirubin is not normally excreted into urine because it is albumin-bound and not water-soluble.

Therefore, bilirubinuria specifically suggests conjugated bilirubin.

Associated jaundice strengthens suspicion for hepatobiliary disease.

Urine That Darkens on Standing

Some pigments become darker after exposure to air or light.

Examples include:

• Porphyrin-related pigments
• Homogentisic acid in alkaptonuria
• Melanin-related pigments
• Certain medication metabolites

The timing of the color change can therefore provide a useful clue.

Black or Very Dark Urine

Potential causes include:

• Severe myoglobinuria
• Hemoglobinuria
• Homogentisic acid
• Melanin-related pigments
• Certain drugs or metabolites

Very dark urine accompanied by muscle pain, weakness, hyperthermia, seizures, or prolonged immobilization should prompt urgent evaluation for rhabdomyolysis.

White, Milky, or Cloudy Urine

Potential causes include:

• Pyuria
• Crystalluria
• Phosphaturia
• Lipiduria
• Chyluria
• Contrast material

Cloudy urine is not synonymous with infection.

Pyuria

Large numbers of leukocytes can produce cloudy urine.

Possible associated findings include:

• Dysuria
• Urinary frequency
• Urgency
• Fever
• Flank pain

Urinalysis and culture are more informative than appearance alone.

Chyluria and Lipiduria

Chyluria

Lymphatic fluid entering the urinary tract may produce a milky appearance.

Lipiduria

May occur with significant renal disease such as nephrotic syndrome.

These are primarily medical rather than toxicologic causes.

Medication-Associated Color Changes

Some particularly useful associations are:

• Riboflavin → fluorescent yellow
• Phenazopyridine → orange/red-orange
• Rifampin → orange-red
• Methylene blue → blue-green
• Propofol → green
• Metronidazole → dark brown
• Nitrofurantoin → brown
• Doxorubicin → reddish
• Levodopa-related metabolites → darkening urine

Medication-related discoloration may be harmless, but the clinical context must still be considered.

Toxicologic Associations

Abnormal urine color becomes particularly important when accompanied by systemic toxicity.

Dark Urine + Muscle Injury

Consider rhabdomyolysis when there is:

• Severe agitation
• Hyperthermia
• Seizures
• Muscle pain
• Muscle weakness
• Prolonged immobilization

Check CK, potassium, renal function, and urinalysis.

Dark Urine + Hemolysis

Consider hemoglobinuria when accompanied by:

• Anemia
• Jaundice
• Weakness
• Elevated LDH
• Reduced haptoglobin

Certain oxidizing drugs and chemicals can precipitate hemolysis, particularly in susceptible individuals.

Cyanosis + Abnormal Dark Urine

Consider methemoglobinemia or associated oxidant exposure, particularly when cyanosis appears disproportionate to pulmonary findings.

Co-oximetry is used to confirm methemoglobinemia.

Dark Urine + Jaundice

Consider:

• Bilirubinuria
• Hepatocellular injury
• Cholestasis
• Hemolysis

Urinalysis and serum bilirubin fractionation help distinguish these possibilities.

Red/Purple Urine + Episodic Abdominal/Neurologic Symptoms

Consider porphyria, particularly when accompanied by:

• Severe abdominal pain
• Autonomic abnormalities
• Neuropsychiatric symptoms
• Peripheral neuropathy
• Hyponatremia

Confirmatory biochemical testing is required.

Diagnostic Approach

Rather than trying to identify a poison from color alone, evaluate the urine systematically.

1. Confirm the color

Determine whether the urine is genuinely:

• Red
• Orange
• Brown
• Green
• Blue
• Purple
• White/cloudy

2. Review exposures

Ask about:

• Prescription drugs
• OTC medications
• Vitamins
• Foods
• Dyes
• Chemicals
• Recent procedures or diagnostic dyes

3. Perform urinalysis

Evaluate:

• Blood/heme
• Bilirubin
• Protein
• Glucose
• Ketones
• Leukocyte esterase
• Nitrite
• Specific gravity
• pH

4. Examine urine microscopically when indicated

Look for:

• RBCs
• WBCs
• Casts
• Crystals
• Organisms

5. Order targeted blood tests

Based on the suspected mechanism.

Important Interpretation of the Urine Blood Dipstick

The older o-tolidine methodology described in the source is obsolete for routine clinical interpretation.

Modern dipsticks react to heme activity.

Therefore:

Dipstick positive + RBCs present

→ Hematuria likely

Dipstick positive + few/no RBCs

→ Consider myoglobinuria or hemoglobinuria

Then use the clinical context:

• Marked CK elevation/muscle injury → myoglobin
• Laboratory evidence of hemolysis → hemoglobin

Useful Laboratory Tests

Depending on the presentation, consider:

• Urinalysis
• Urine microscopy
• CBC
• Electrolytes
• BUN/creatinine
• CK
• AST/ALT
• Total and direct bilirubin
• LDH
• Haptoglobin
• Peripheral smear

Specialized testing should be guided by the suspected disease or toxic exposure.

Management

Urine discoloration itself generally does not require treatment.

Management should target the underlying cause.

Examples:

• Dehydration → appropriate fluid replacement
• Rhabdomyolysis → supportive management and prevention/treatment of complications
• Hemolysis → identify and remove the cause; treat complications
• Hepatobiliary disease → cause-specific management
• UTI → appropriate antimicrobial treatment when indicated
• Methemoglobinemia → specific treatment when clinically significant
• Poisoning → toxin-specific supportive or antidotal therapy

Benign medication-related discoloration generally resolves after the responsible compound and its metabolites are eliminated.

Red Flags

Abnormal urine color warrants greater concern when accompanied by:

• Reduced urine output
• Acute kidney injury
• Severe muscle pain or weakness
• Hyperthermia
• Repeated seizures
• Jaundice
• Significant anemia
• Hypotension
• Cyanosis
• Altered mental status
• Severe abdominal pain
• Significant toxic exposure

These findings suggest that the discoloration may represent a systemic process rather than a harmless pigment.

Key Points

• Urine color is influenced by concentration, endogenous pigments, foods, medications, and disease.
• Abnormal urine color is a clue rather than a diagnosis.
• Red urine does not necessarily indicate bleeding.
• Hematuria = urine heme positive with RBCs on microscopy.
• Myoglobinuria or hemoglobinuria = urine heme positive with few/no RBCs.
• Myoglobinuria should prompt evaluation for rhabdomyolysis, including CK and renal function.
• Hemoglobinuria suggests intravascular hemolysis when supported by other laboratory findings.
• Unconjugated bilirubin is not normally present in urine; bilirubinuria reflects conjugated bilirubin.
• Riboflavin commonly causes bright fluorescent yellow urine.
• Phenazopyridine commonly causes orange urine.
• Rifampin can produce orange-red discoloration of urine and other body fluids.
• Methylene blue may produce blue-green urine.
• Propofol can occasionally produce green urine.
• Metronidazole and nitrofurantoin may cause brown or dark urine.
• Some pigments, including porphyrin-related compounds, may darken after the urine stands.
• White or cloudy urine may reflect WBCs, crystals, lipids, or chyle and is not automatically a UTI.
• Medication-related urine discoloration is often benign, but associated systemic findings determine whether further investigation is necessary.

Toxicology – Approach to an Unknown Ingestion

Core Concept

An unknown ingestion should be approached as a potentially serious poisoning when there is evidence or reasonable suspicion that a drug, chemical, or other toxic substance was taken but the exact agent, amount, or both are uncertain.

The exposure may ultimately prove to be:

• Essentially nontoxic
• A toxic substance taken below a clinically important amount
• A potentially dangerous or life-threatening poisoning
• A mixed ingestion involving several substances

A normal initial examination does not reliably exclude significant poisoning because some toxic effects are delayed.

Immediate Priorities

Management should begin before the exact substance is identified.

A useful initial approach is:

Stabilize → recognize toxidromes → obtain focused history → ECG/glucose/basic investigations → identify high-risk occult poisons → give specific treatment when indicated → reassess repeatedly

The first priorities are:

• Airway protection
• Adequate ventilation
• Oxygenation
• Circulation and tissue perfusion
• Mental status
• Temperature
• Rapid bedside glucose
• Recognition and treatment of seizures or dangerous dysrhythmias

History: Reconstruct the Exposure

The history should be gathered from multiple sources, especially when the patient is confused, unconscious, very young, or unwilling to provide details.

Useful information includes:

• Medications prescribed to the patient
• Medications belonging to household members
• Over-the-counter products
• Herbal or complementary products
• Alcohol and recreational substances
• Household chemicals
• Automotive products
• Pesticides
• Occupational chemicals
• Time the patient was last known well
• Time the exposure may have occurred
• Whether extended-release products are available
• Possibility of multiple substances

Information from family, caregivers, emergency personnel, medication lists, pharmacy records, containers, and scene findings can be valuable.

Empty containers alone do not establish the amount actually ingested.

Do Not Assume Poisoning

Even when an overdose is suspected, consider important alternative diagnoses.

These include:

• Hypoglycemia
• Sepsis
• Meningitis or encephalitis
• Stroke
• Intracranial hemorrhage
• Head trauma
• Seizure/postictal state
• Electrolyte disturbances
• Diabetic ketoacidosis
• Hepatic or uremic encephalopathy
• Hypoxia
• Endocrine emergencies

Poisoning should likewise remain in the differential diagnosis of otherwise unexplained altered mental status or abnormal vital signs.

Toxidrome-Based Assessment

A toxidrome is a recognizable combination of clinical findings suggesting a particular pharmacologic effect.

Toxidromes can narrow the differential, but:

Absence of a classic toxidrome does not exclude poisoning.

Mixed ingestions can also produce overlapping or contradictory findings.

Opioid Pattern

Typical findings include:

• CNS depression
• Bradypnea or apnea
• Miosis

Additional findings may include:

• Hypotension
• Bradycardia
• Hypothermia

The most important manifestation is inadequate ventilation.

Naloxone is indicated when clinically important opioid-induced respiratory depression is suspected.

The therapeutic goal is restoration of adequate ventilation rather than necessarily complete awakening.

Sedative-Hypnotic Pattern

Possible findings include:

• Somnolence
• Slurred speech
• Ataxia
• Nystagmus
• Respiratory depression
• Hypothermia

Potential causes include:

• Benzodiazepines
• Barbiturates
• Ethanol
• Other sedative agents

Profound coma should prompt consideration of coingestants and nontoxic neurologic or metabolic causes.

Anticholinergic Pattern

Characteristic findings include:

• Agitation or delirium
• Mydriasis
• Tachycardia
• Dry mucous membranes
• Dry, flushed skin
• Reduced bowel sounds
• Urinary retention
• Hyperthermia

Potential causes include:

• First-generation antihistamines
• Antimuscarinic medications
• TCAs
• Certain antipsychotics
• Toxic plants

Some agents, particularly TCAs and certain antihistamines, can additionally cause sodium-channel blockade and QRS widening.

Sympathomimetic Pattern

Typical findings include:

• Agitation
• Mydriasis
• Tachycardia
• Hypertension
• Diaphoresis
• Hyperthermia

Severe poisoning can cause:

• Seizures
• Dysrhythmias
• Rhabdomyolysis
• Metabolic acidosis
• Cardiovascular collapse

Examples include cocaine and amphetamine-type stimulants.

A useful distinction is:

Sympathomimetic → sweaty

Anticholinergic → dry

Cholinergic Pattern

Typical muscarinic findings include:

• Miosis
• Salivation
• Lacrimation
• Bronchorrhea
• Bronchospasm
• Vomiting
• Diarrhea
• Sweating

Nicotinic manifestations include:

• Fasciculations
• Weakness
• Paralysis

Severe poisoning can result in respiratory failure from a combination of:

Secretions + bronchospasm + respiratory muscle weakness + CNS toxicity

Organophosphate and carbamate pesticides are important causes.

Vital Signs as Diagnostic Clues

Respiratory Depression

Consider:

• Opioids
• Sedative-hypnotics
• Severe CNS-depressant poisoning

Evaluate ventilation, not simply oxygen saturation.

Rapid or Deep Breathing

Consider:

• Salicylates
• Methanol
• Ethylene glycol
• Carbon monoxide
• Severe metabolic acidosis
• Stimulants
• Theophylline
• Pulmonary injury

Deep, rapid breathing may represent essential compensation for metabolic acidosis.

Tachycardia

Potential causes include:

• Sympathomimetics
• Anticholinergics
• Theophylline
• β₂-agonists
• Withdrawal
• Hypovolemia
• Hyperthermia
• Hypoxia

Bradycardia

Consider:

• Beta-blockers
• Calcium channel blockers
• Digoxin
• Clonidine/imidazolines
• Cholinergic poisoning

The associated blood pressure, ECG, glucose, pupils, respiratory status, and mental state help differentiate them.

Hyperthermia

Important toxicologic causes include:

• Sympathomimetic toxicity
• Anticholinergic toxicity
• Serotonin syndrome
• Neuroleptic malignant syndrome
• MAOI toxicity
• Severe withdrawal

Marked hyperthermia can rapidly produce rhabdomyolysis and multiorgan injury.

Hypothermia

Consider:

• Sedative-hypnotics
• Opioids
• Ethanol
• Antipsychotics
• Prolonged immobilization or environmental exposure

Pupils and Eye Findings

Miosis

Consider:

• Opioids
• Organophosphates/carbamates
• Clonidine or related imidazolines

Pupil size alone is not diagnostic.

Mydriasis

Consider:

• Sympathomimetics
• Anticholinergics
• Hypoxia
• Certain hallucinogens

Nystagmus

May occur with:

• PCP
• Carbamazepine
• Phenytoin
• Sedative/intoxicating agents

Visual Disturbance

Important possibilities include:

• Methanol
• Digoxin
• Carbon monoxide
• Certain other neurologic toxicants

Visual symptoms combined with otherwise unexplained high-anion-gap acidosis are particularly concerning for methanol poisoning.

Skin Findings

Dry, Flushed Skin

Supports anticholinergic toxicity.

Diaphoresis

Consider:

• Sympathomimetics
• Cholinergic poisoning
• Withdrawal
• Salicylates
• Hypoglycemia

Cyanosis

Consider:

• Hypoxemia
• Methemoglobinemia

Persistent cyanosis with unexpectedly preserved PaO₂ should raise concern for a dyshemoglobinemia.

Bullae After Prolonged Unconsciousness

Pressure-related bullous lesions may occur after prolonged coma from several intoxicants and should not be regarded as specific for one poison.

Cardiovascular Clues

An ECG is one of the highest-yield tests in an unknown ingestion.

Assess:

• Rhythm
• PR interval
• QRS duration
• QT/QTc
• AV conduction
• Ventricular ectopy
• Ischemic changes

QRS Widening

QRS widening should raise concern for sodium-channel blockade.

Important toxicologic causes include:

• TCAs
• Certain antihistamines
• Class I antiarrhythmics
• Some other membrane-stabilizing drugs

Severe sodium-channel toxicity may cause:

• Hypotension
• Seizures
• Ventricular dysrhythmias

Sodium bicarbonate is an important treatment when clinically significant sodium-channel blockade is present.

QT Prolongation

QT prolongation can occur with many medications and electrolyte abnormalities.

Important contributing factors include:

• QT-prolonging antidepressants or antipsychotics
• Certain antiarrhythmics
• Methadone
• Hypokalemia
• Hypomagnesemia
• Hypocalcemia

Marked QT prolongation increases the risk of torsades de pointes.

AV Block

Consider:

• Digoxin
• Beta-blockers
• Calcium channel blockers
• Other conduction-suppressing drugs

The overall clinical syndrome helps distinguish these causes.

Respiratory Findings

Bronchorrhea

Prominent airway secretions suggest:

• Organophosphate poisoning
• Carbamate poisoning
• Severe nicotine toxicity in an appropriate exposure

Bronchospasm

Possible causes include:

• Irritant gases
• Cholinergic poisoning
• Caustic inhalation
• Certain medication reactions

Pulmonary Infiltrates

Consider:

• Aspiration
• Hydrocarbon pneumonitis
• Irritant-gas injury
• Noncardiogenic pulmonary edema
• Infection

A normal initial chest radiograph does not exclude evolving toxic lung injury.

Gastrointestinal Clues

Repeated Vomiting

Consider:

• Iron
• Theophylline
• Digoxin
• Salicylates
• Cholinergic poisoning
• Caustic exposure
• Heavy metals

Reduced Bowel Sounds

Suggest:

• Anticholinergic toxicity
• Opioid effects

Diarrhea and Hyperactive GI Function

Consider:

• Cholinergic poisoning
• Nicotine
• Withdrawal
• Certain toxic mushrooms

Hepatic Injury

Severe hepatocellular injury after an unknown ingestion should immediately raise concern for acetaminophen toxicity, even when the history is unclear.

Other drugs and chemicals can also cause hepatic injury, but acetaminophen is especially important because:

• Early symptoms may be mild or absent.
• Severe hepatic injury is delayed.
• Effective antidotal treatment is available.

A serum acetaminophen concentration is therefore commonly obtained in potentially significant intentional or unexplained ingestions.

Renal Findings

Acute kidney injury may result from:

• Shock
• Rhabdomyolysis
• Ethylene glycol
• Heavy metals
• Direct nephrotoxic drugs
• Prolonged severe poisoning

Dark urine may reflect myoglobinuria after seizures, hyperthermia, prolonged immobilization, or severe agitation.

Electrolyte Clues

Hyperkalemia

Potential toxicologic causes include:

• Digoxin
• Potassium-containing products
• Potassium-sparing medications
• Severe tissue injury
• Severe acidosis

Hyperkalemia should be interpreted together with renal function and ECG findings.

Hypokalemia

Consider:

• β₂-agonists
• Theophylline
• Caffeine
• Barium
• Potassium-wasting diuretics

Marked hypokalemia increases the risk of dysrhythmias.

Hyponatremia

Possible mechanisms include:

• Excess free-water intake
• Drug-induced SIADH
• Certain anticonvulsants or psychotropic medications

Severe acute hyponatremia may cause:

• Confusion
• Seizures
• Coma

High-Anion-Gap Metabolic Acidosis

An unexplained high-anion-gap metabolic acidosis is a major clue in an unknown poisoning.

Consider:

• Methanol
• Ethylene glycol
• Salicylates
• Lactic acidosis
• Severe iron poisoning
• Ketoacidosis
• Renal failure

Other toxicants can produce acidosis through shock, seizures, or mitochondrial dysfunction.

The pattern should be interpreted with:

• Blood gas
• Lactate
• Glucose
• Renal function
• Osmolal gap when appropriate
• Exposure history
• Targeted toxicant concentrations

Neurologic Clues

Ataxia

Consider:

• Ethanol
• Benzodiazepines
• Phenytoin
• Carbamazepine
• Lithium
• Other sedative-hypnotics

Agitated Delirium

Consider:

• Anticholinergic agents
• Stimulants
• Hallucinogens
• Withdrawal
• Hyperthermic syndromes

Coma

Important toxicologic causes include:

• Opioids
• Sedative-hypnotics
• Clonidine
• Anticonvulsants
• Toxic alcohols
• Carbon monoxide
• Severe cardiotoxic poisoning

Always evaluate for nontoxicologic causes as well.

Seizures

Important possibilities include:

• Bupropion
• TCAs
• Isoniazid
• Theophylline
• Stimulants
• Antihistamines
• Camphor
• Withdrawal
• Hypoglycemia

Refractory seizures should prompt consideration of isoniazid toxicity in the appropriate setting.

Rhabdomyolysis

Rhabdomyolysis can follow:

• Severe agitation
• Hyperthermia
• Repeated seizures
• Prolonged immobilization
• Stimulant poisoning
• Serotonin syndrome
• NMS

Evaluation may include:

• CK
• Potassium
• Renal function
• Urinalysis
• ECG

Glucose: Check Early

Bedside glucose should be obtained early in any patient with:

• Altered mental status
• Seizures
• Unexplained autonomic abnormalities
• Suspected overdose

Hypoglycemia may result from:

• Insulin
• Sulfonylureas and related insulin secretagogues
• Ethanol, particularly in young children or susceptible patients
• Severe systemic illness
• Certain other medications

Neuroglycopenia may mimic intoxication.

Initial Diagnostic Workup

Testing should be individualized, but an important baseline evaluation for a significant unknown ingestion often includes:

• Bedside glucose
• Electrolytes
• Bicarbonate
• BUN/creatinine
• ECG
• Continuous cardiac monitoring when appropriate

Additional tests depend on clinical findings.

Acetaminophen and Salicylate Testing

These deserve particular attention because clinically important poisoning can initially be subtle.

In intentional or significant unknown ingestions, clinicians commonly consider measuring:

• Serum acetaminophen concentration
• Serum salicylate concentration

Serial salicylate concentrations may be required when poisoning is suspected because absorption can be delayed and concentrations may continue to rise.

Additional Targeted Testing

Depending on the presentation, consider:

• Calcium and magnesium
• Blood gas
• Lactate
• CK
• Liver tests
• Serum osmolality
• Ethanol concentration
• Lithium concentration
• Digoxin concentration
• Theophylline concentration
• Carbon monoxide testing
• Methemoglobin measurement
• Methanol/ethylene glycol testing

Testing should be driven by the clinical syndrome and plausible exposure.

Urine Drug Screens

Routine urine immunoassay screening has important limitations.

A positive result may indicate previous exposure without proving:

• Current intoxication
• Dose
• Timing
• Causation

A negative screen also does not exclude poisoning, because many important drugs are poorly detected or not included.

Therefore:

Clinical assessment + ECG + targeted laboratory testing are usually more useful than relying on a broad drug screen.

Imaging

Imaging should answer a specific clinical question.

Head CT

Consider when there is:

• Trauma
• Focal neurologic deficit
• Intracranial hemorrhage concern
• Unexplained persistent coma
• Another suspected structural CNS disorder

Chest Imaging

Consider for:

• Respiratory distress
• Aspiration
• Pulmonary edema
• Hydrocarbon exposure
• Inhalational injury

Abdominal Imaging

May occasionally identify certain radiopaque substances or foreign bodies, but:

A normal abdominal radiograph does not exclude ingestion.

Management Before the Poison Is Identified

Supportive care is the foundation of treatment.

Treat immediately reversible threats as they appear:

• Hypoxia → respiratory support
• Hypoglycemia → glucose correction
• Seizures → benzodiazepines
• Opioid respiratory depression → naloxone
• Hyperthermia → active cooling
• Sodium-channel blockade → sodium bicarbonate
• Shock → mechanism-directed circulatory support
• Dangerous electrolyte abnormalities → appropriate correction

Treatment should not be delayed while waiting for a definitive toxicologic diagnosis.

Empiric Antidotes

There is no universal antidote cocktail for every unknown ingestion.

Antidotes should be used when the clinical syndrome or available evidence supports a particular poisoning.

Examples include:

• Naloxone for suspected opioid-induced respiratory depression
• Sodium bicarbonate for significant sodium-channel blockade
• Pyridoxine for suspected isoniazid-associated refractory seizures
• Fomepizole when toxic alcohol poisoning is sufficiently suspected
• Digoxin immune Fab for clinically important digoxin toxicity
• Atropine ± pralidoxime for significant organophosphate poisoning

The risk-benefit profile of each antidote should guide empiric use.

Decontamination

Induced Vomiting

Do not induce vomiting.

Gastric Lavage

Routine gastric lavage is not recommended for unknown ingestion.

It carries risks including:

• Aspiration
• Airway injury
• Gastrointestinal injury

Its role is exceptionally limited and should not be treated as routine management of serious overdose.

Activated Charcoal

Activated charcoal may be considered for a selected recent ingestion of a clinically important, charcoal-adsorbable substance.

It should generally be avoided when:

• The airway is unprotected.
• Aspiration risk is substantial.
• Ileus or obstruction is present.
• The substance is poorly adsorbed.
• Its use would delay resuscitation or antidotal treatment.

An unknown ingestion by itself does not automatically justify charcoal.

Observation

The traditional idea that every asymptomatic unknown ingestion can automatically be discharged after a fixed 6-hour observation period is too simplistic.

Observation must account for:

• Suspected substance
• Immediate- versus extended-release formulation
• Time of exposure
• Reliability of the history
• ECG findings
• Laboratory abnormalities
• Development of symptoms
• Possibility of delayed metabolites
• Coingestants

Some dangerous poisonings can remain asymptomatic for longer periods.

Examples include:

• Extended-release medications
• Certain calcium channel blockers
• Bupropion XL
• Methanol
• Ethylene glycol
• Acetaminophen
• Sulfonylureas
• Long-acting opioids
• Delayed organ-toxic exposures

Disposition

Discharge should be based on a sufficiently reassuring overall risk assessment, not simply disappearance of symptoms.

Before discharge, clinicians should establish that:

• The patient is clinically stable.
• Appropriate observation has been completed.
• ECG abnormalities are absent or appropriately resolved.
• Important laboratory abnormalities have been addressed.
• Delayed toxicity is not reasonably expected.
• Appropriate psychiatric assessment has occurred when intentional self-harm is involved.
• A safe disposition and follow-up plan are available.

Patients with significant toxicity, uncertain high-risk exposure, persistent abnormalities, or expected delayed effects require continued observation or admission.

Important Pitfalls

• Do not assume that an asymptomatic patient had a harmless ingestion.
• Do not diagnose poisoning solely from one pupil, skin, or vital-sign abnormality.
• Mixed overdoses may distort classic toxidromes.
• A negative urine drug screen does not exclude important poisoning.
• Do not overlook acetaminophen or salicylates in an intentional unknown ingestion.
• A normal initial ECG does not eliminate every delayed cardiotoxic exposure.
• Normal early laboratory results may precede delayed organ toxicity.
• Do not attribute altered mental status to intoxication until important neurologic, metabolic, infectious, and traumatic causes have been considered.
• Do not use a universal observation period for every unknown ingestion.
• Do not let decontamination delay resuscitation.

Key Points

• An unknown ingestion should initially be treated as potentially toxic until adequate assessment establishes otherwise.
• Stabilization takes priority over identifying the exact poison.
• Obtain information from the patient, witnesses, medication history, available containers, and scene information.
• Use toxidromes as diagnostic clues, not absolute diagnostic rules.
• Early bedside glucose and ECG are particularly valuable.
• Intentional or clinically significant unknown ingestions often warrant consideration of acetaminophen and salicylate concentrations.
• QRS widening should raise concern for sodium-channel blockade.
• High-anion-gap metabolic acidosis should prompt consideration of toxic alcohols, salicylates, lactate-producing poisonings, and important nontoxic causes.
• Naloxone should be used when suspected opioid toxicity causes inadequate ventilation.
• Broad urine toxicology screens have substantial limitations.
• Routine induced vomiting and gastric lavage are not recommended.
• Activated charcoal is reserved for selected appropriate ingestions, not automatically given whenever the substance is unknown.
• A normal initial examination does not exclude delayed toxicity.
• Observation and disposition must be based on the suspected exposure and toxicokinetics rather than a universal fixed time.
• Always keep nontoxicologic disease in the differential diagnosis of an apparently poisoned patient.

Toxicology – Tachycardia

Definition

Tachycardia is an abnormally elevated heart rate relative to age and physiologic state.

In adults, resting heart rate >100 beats/min is generally considered tachycardia.

In children, normal heart rate varies substantially with age, activity, fever, distress, and clinical condition. Therefore, pediatric tachycardia should be interpreted using age-appropriate reference ranges rather than a single rigid cutoff.

Tachycardia is a clinical sign rather than a diagnosis. In toxicology, identifying the mechanism and underlying poison is more important than simply reducing the heart rate.

Pathophysiology

Toxicant-associated tachycardia can develop through several mechanisms:

• Excess sympathetic stimulation
• β-adrenergic receptor stimulation
• Muscarinic receptor blockade
• Peripheral vasodilation with reflex tachycardia
• Myocardial irritability
• Drug-induced dysrhythmia
• Hyperthermia
• Hypoxia
• Hypotension
• Hypovolemia
• Metabolic acidosis
• Withdrawal syndromes

A rapid heart rate may therefore represent an appropriate compensatory response rather than primary cardiac toxicity.

Major Toxicologic Mechanisms

Sympathomimetic Stimulation

Sympathomimetics increase catecholaminergic activity.

Important causes include:

• Cocaine
• Amphetamines
• Methamphetamine
• Ephedrine
• Other stimulants
• β₂-adrenergic agonists

Typical findings include:

• Tachycardia
• Hypertension
• Mydriasis
• Diaphoresis
• Agitation
• Tremor
• Hyperthermia

Severe toxicity can produce:

• Seizures
• Rhabdomyolysis
• Dysrhythmias
• Myocardial ischemia
• Metabolic acidosis

Anticholinergic Toxicity

Antimuscarinic drugs commonly produce sinus tachycardia.

Potential causes include:

• Diphenhydramine
• Other first-generation antihistamines
• Atropine
• Scopolamine
• Antipsychotics with antimuscarinic activity
• Jimsonweed and related plants

Clinical findings include:

• Tachycardia
• Mydriasis
• Dry mucous membranes
• Dry, flushed skin
• Hyperthermia
• Urinary retention
• Reduced bowel sounds
• Agitation
• Hallucinations
• Delirium

A useful distinction from sympathomimetic toxicity is:

Anticholinergic → hot and dry

Sympathomimetic → hot and sweaty

Tricyclic Antidepressants

TCA poisoning commonly causes tachycardia through:

• Antimuscarinic activity
• Norepinephrine reuptake inhibition
• Cardiovascular toxicity

More concerning findings include:

• Altered mental status
• Seizures
• Hypotension
• QRS widening
• Ventricular dysrhythmias

Tachycardia accompanied by QRS widening and hypotension should raise concern for significant sodium-channel blockade.

Sodium bicarbonate is the major treatment for clinically important TCA-related sodium-channel cardiotoxicity.

Other Sodium-Channel-Blocking Drugs

Several drugs can produce:

Tachycardia + QRS widening + hypotension ± ventricular dysrhythmias

Examples include:

• TCAs
• Certain first-generation antihistamines
• Class IA antiarrhythmics
• Some other membrane-stabilizing drugs

ECG evaluation is therefore essential in toxicologic tachycardia.

Theophylline

Theophylline toxicity commonly produces marked tachycardia.

Associated findings include:

• Nausea and vomiting
• Tremor
• Agitation
• Hypokalemia
• Hyperglycemia
• Seizures
• Supraventricular or ventricular dysrhythmias

Severe theophylline poisoning can deteriorate rapidly.

β₂-Adrenergic Agonists

Excessive β₂-agonist exposure can produce:

• Tachycardia
• Tremor
• Hypokalemia
• Hyperglycemia
• Lactic acidosis

The heart-rate elevation may result from both direct β-receptor effects and physiologic responses to metabolic changes.

Digoxin

Digoxin toxicity does not have one characteristic heart rate.

It can cause numerous rhythm disturbances, including combinations of:

• Bradycardia
• AV block
• Atrial tachyarrhythmias
• Ventricular ectopy
• Ventricular tachycardia

Associated findings may include:

• Nausea/vomiting
• Confusion
• Visual disturbances
• Hyperkalemia in significant acute poisoning

The combination of a tachyarrhythmia with AV conduction abnormalities can suggest digoxin toxicity.

Monoamine Oxidase Inhibitors

MAOI toxicity may produce:

• Tachycardia
• Hypertension
• Hyperthermia
• Agitation
• Altered mental status
• Neuromuscular abnormalities

Severe poisoning can progress to:

• Seizures
• Rigidity
• Cardiovascular instability
• Coma

Serotonergic Drugs

Serotonergic toxicity may cause tachycardia as part of autonomic hyperactivity.

Serotonin syndrome typically includes:

• Agitation
• Diaphoresis
• Tachycardia
• Hyperthermia
• Hyperreflexia
• Tremor
• Clonus

Clonus and hyperreflexia are particularly useful diagnostic findings.

Isolated SSRI overdose is often less severe than serotonin syndrome caused by significant serotonergic interactions or more toxic serotonergic agents.

Carbamazepine

Carbamazepine toxicity may produce:

• Tachycardia
• Nystagmus
• Ataxia
• CNS depression
• Coma
• Seizures

Severe poisoning can also produce cardiac conduction abnormalities.

Cholinergic Poisoning

Organophosphate and carbamate poisoning are commonly associated with bradycardia, but tachycardia can also occur.

Clinical findings include:

• Miosis
• Salivation
• Lacrimation
• Sweating
• Bronchorrhea
• Vomiting
• Diarrhea
• Fasciculations
• Weakness

Heart rate alone should therefore not be used to exclude a cholinergic syndrome.

Methemoglobinemia

Methemoglobinemia reduces effective oxygen delivery.

Compensatory findings may include:

• Tachycardia
• Tachypnea
• Cyanosis
• Headache
• Dizziness
• Dyspnea

A characteristic clue is cyanosis with an oxygen saturation that does not improve as expected with supplemental oxygen.

Diagnosis is confirmed using co-oximetry.

Thyroid Hormone Toxicity

Excess thyroid hormone can cause:

• Persistent tachycardia
• Tremor
• Anxiety
• Diaphoresis
• Hyperthermia
• Hypertension

Severe thyrotoxicosis may produce:

• Atrial fibrillation
• Heart failure
• Delirium
• Cardiovascular instability

Symptoms after an acute thyroid hormone ingestion may be delayed because hormonal effects develop over time.

Vasodilators

Vasodilator medications may produce reflex tachycardia secondary to reduced systemic vascular resistance.

Examples include:

• Dihydropyridine calcium channel blockers
• Hydralazine
• Nitrates

The key mechanism is:

Vasodilation → decreased blood pressure → baroreceptor activation → sympathetic response → tachycardia

Withdrawal Syndromes

Withdrawal from certain substances may produce autonomic hyperactivity.

Important causes include:

• Alcohol
• Benzodiazepines
• Barbiturates
• Opioids

Possible findings include:

• Tachycardia
• Hypertension
• Diaphoresis
• Tremor
• Anxiety
• Agitation

Alcohol or sedative-hypnotic withdrawal may additionally cause:

• Hallucinations
• Hyperthermia
• Seizures

Nontoxicologic Causes

Not every tachycardia in a poisoned patient is directly caused by the toxicant.

Important alternative causes include:

• Pain
• Anxiety
• Fever
• Dehydration
• Hemorrhage
• Anemia
• Hypoxia
• Pulmonary embolism
• Sepsis
• Metabolic acidosis
• Hyperthyroidism
• Cardiac dysrhythmia

Persistent unexplained tachycardia should prompt investigation for these conditions.

Clinical Assessment

The first important question is whether the rhythm represents:

Sinus tachycardia or a primary tachydysrhythmia?

Sinus tachycardia is usually a physiologic response to an underlying problem.

A primary tachydysrhythmia may require rhythm-specific management.

Vital-Sign Patterns

Tachycardia + Hypertension

Consider:

• Sympathomimetics
• Anticholinergic poisoning
• MAOI toxicity
• Serotonin syndrome
• Alcohol or sedative withdrawal
• Hyperthermia

Tachycardia + Hypotension

Consider:

• TCA poisoning
• Theophylline toxicity
• Severe vasodilator poisoning
• Chloroquine/hydroxychloroquine toxicity
• Shock
• Volume depletion

This combination is particularly concerning for cardiovascular toxicity or hemodynamic compromise.

Tachycardia + Hyperthermia

Consider:

• Sympathomimetic toxicity
• Anticholinergic toxicity
• Serotonin syndrome
• MAOI toxicity
• Severe withdrawal
• Thyrotoxicosis

Hyperthermia substantially increases the risk of:

• Rhabdomyolysis
• Metabolic acidosis
• Acute kidney injury
• Dysrhythmias
• Multiorgan failure

Pupil and Skin Findings

Mydriasis + Diaphoresis

Suggests:

Sympathomimetic syndrome

Mydriasis + Dry Skin

Suggests:

Anticholinergic syndrome

Miosis + Secretions

Suggests:

Cholinergic syndrome

Cyanosis

Consider:

• Severe hypoxemia
• Methemoglobinemia

Gastrointestinal Findings

Vomiting

May occur with:

• Theophylline
• Salicylates
• Iron
• Digoxin
• Cholinergic poisoning

Reduced Bowel Sounds

Supports an anticholinergic syndrome.

Diarrhea + Excessive Secretions

Supports a cholinergic syndrome.

Neurologic Findings

Agitation and Delirium

Consider:

• Stimulants
• Anticholinergic agents
• Hallucinogens
• Withdrawal

Tremor

Consider:

• Theophylline
• β₂-agonists
• Stimulants
• Thyroid hormone
• Withdrawal

Seizures

Tachycardia accompanied by seizures should raise concern for:

• TCAs
• Bupropion
• Theophylline
• Stimulants
• Antihistamines
• MAOIs
• Severe withdrawal

ECG Evaluation

An ECG should be obtained in persistent or clinically significant toxicologic tachycardia.

Assess:

• Rhythm
• Heart rate
• PR interval
• QRS duration
• QT/QTc
• AV conduction
• Ventricular ectopy
• Ischemic abnormalities

Continuous cardiac monitoring is appropriate when significant poisoning or dysrhythmia is suspected.

QRS Widening

Tachycardia with QRS widening should raise concern for sodium-channel blockade.

Important causes include:

• TCAs
• Class IA antiarrhythmics
• Certain antihistamines
• Other sodium-channel-blocking medications

A prominent terminal R wave in lead aVR can support sodium-channel blockade, but it is not specific enough to diagnose TCA poisoning by itself.

QT Prolongation

Certain toxicants can prolong ventricular repolarization and increase the risk of torsades de pointes.

Potential causes include:

• Some antiarrhythmics
• Antipsychotics
• Certain antidepressants
• Methadone
• Other QT-prolonging medications

Evaluate and correct contributing abnormalities such as:

• Hypokalemia
• Hypomagnesemia
• Bradycardia when clinically relevant

Laboratory Evaluation

Testing should be guided by the clinical presentation.

Possible studies include:

• Bedside glucose
• CBC
• Electrolytes
• Bicarbonate
• Potassium
• Magnesium
• Renal function
• Blood gas
• Lactate
• CK when rhabdomyolysis is suspected

Targeted toxicologic tests may include:

• Salicylate concentration
• Acetaminophen concentration when overdose is possible
• Digoxin concentration
• Theophylline concentration
• Other drug-specific concentrations

Broad urine toxicology screening has limited sensitivity and specificity and should not replace clinical assessment.

Tachycardia With Metabolic Acidosis

Unexplained tachycardia accompanied by metabolic acidosis requires careful investigation.

Potential causes include:

• Salicylates
• Toxic alcohols
• Carbon monoxide
• Cyanide
• Severe stimulant toxicity
• Seizures
• Shock
• Sepsis
• Diabetic ketoacidosis

The anion gap, lactate, blood gas, exposure history, and targeted toxicology testing can help determine the cause.

Management Principles

The major principle is:

Treat the cause of the tachycardia rather than the heart rate alone.

Examples:

• Hypoxia → improve oxygenation/ventilation
• Hypovolemia → appropriate fluid replacement
• Hyperthermia → rapid cooling
• Hypoglycemia → correct glucose
• Electrolyte abnormality → correct the disturbance
• Agitation → appropriate sedation
• Sodium-channel blockade → sodium bicarbonate
• Withdrawal → syndrome-specific treatment

Agitation-Related Tachycardia

Agitation itself can substantially increase sympathetic activity.

When agitation results from stimulant toxicity or withdrawal, benzodiazepines are often first-line therapy.

Appropriate sedation can improve:

• Tachycardia
• Hypertension
• Agitation
• Muscle activity
• Hyperthermia risk

Airway and respiratory status should be monitored during sedative treatment.

Beta-Blockers

Beta-blockade should not be used routinely simply to normalize toxicologic sinus tachycardia.

The appropriateness of a beta-blocker depends on:

• Toxicant involved
• Blood pressure
• Rhythm
• Presence of myocardial ischemia
• Degree of sympathetic stimulation

In stimulant-associated cardiovascular toxicity, treatment generally emphasizes sedation and appropriate vasodilator therapy when needed, rather than reflexively treating the heart rate with isolated beta-blockade.

Hypotension

When tachycardia accompanies hypotension, determine whether the cause is:

• Hypovolemia
• Vasodilation
• Myocardial depression
• Dysrhythmia
• Severe metabolic toxicity

Fluids should be administered according to the patient’s volume status and response.

Persistent shock may require:

• Vasopressors
• Toxin-specific cardiovascular therapy
• Advanced circulatory support in selected severe poisonings

Routine large-volume fluid administration should be avoided when cardiogenic toxicity is possible.

Hypertension

When tachycardia and hypertension result from severe sympathetic activation:

Control agitation and sympathetic excess first.

Benzodiazepines are particularly useful for stimulant-related agitation.

Persistent severe hypertension or acute target-organ injury may require a short-acting, titratable antihypertensive agent selected according to the toxicant and clinical situation.

Decontamination

Induced vomiting is not recommended.

Routine gastric lavage is generally not indicated.

Activated charcoal may be considered for selected recent, serious, adsorbable ingestions when:

• The expected benefit is meaningful.
• Aspiration risk is acceptable.
• The airway is adequately protected.

Decontamination should never delay cardiovascular stabilization.

Monitoring

Patients with significant toxicologic tachycardia should be monitored for:

• Heart rate and rhythm
• Blood pressure
• Mental status
• Temperature
• Oxygenation
• QRS and QT abnormalities
• Electrolyte disturbances

Additional monitoring depends on the suspected poison.

Disposition

Disposition depends primarily on the underlying toxicant and associated abnormalities, rather than the heart rate alone.

Hospital observation or admission may be necessary when there is:

• Persistent unexplained tachycardia
• QRS or QT abnormalities
• Hypotension
• Severe hypertension
• Hyperthermia
• Seizures
• Altered mental status
• Significant metabolic abnormalities
• Potential delayed toxicity

Key Points

• Tachycardia is a clinical sign, not a specific diagnosis.
• In adults, resting heart rate >100 beats/min generally meets the definition of tachycardia; pediatric interpretation is age-dependent.
• Common toxicologic mechanisms include sympathetic stimulation, anticholinergic activity, reflex tachycardia, hyperthermia, hypoxia, hypotension, and volume depletion.
• Sympathomimetic toxicity causes tachycardia with diaphoresis, whereas anticholinergic toxicity typically causes tachycardia with dry skin and mucous membranes.
• Important toxicologic causes include stimulants, TCAs, antihistamines, theophylline, β₂-agonists, MAOIs, serotonergic drugs, thyroid hormone, and withdrawal syndromes.
• Tachycardia with QRS widening should raise concern for sodium-channel-blocking toxicity.
• A terminal R wave in aVR may support sodium-channel blockade but is not specific for TCA poisoning.
• Theophylline and β₂-agonist toxicity may produce hypokalemia.
• Tachycardia with cyanosis should raise concern for hypoxemia or methemoglobinemia.
• Obtain an ECG in clinically significant or unexplained toxicologic tachycardia.
• Management should focus on the underlying cause rather than simply lowering the heart rate.
• Benzodiazepines are often useful when tachycardia is driven by stimulant-induced agitation or withdrawal.
• Beta-blockers should not be used reflexively for toxicologic sinus tachycardia.
• Persistent tachycardia accompanied by hypotension, hyperthermia, altered mental status, seizures, QRS widening, or metabolic acidosis suggests potentially severe poisoning.

Toxicology – Toxicant-Induced Seizures

Definition

A seizure is a transient episode of abnormal, excessive neuronal activity that may produce:

• Involuntary motor activity
• Altered or loss of consciousness
• Sensory or behavioral abnormalities
• Autonomic manifestations

In toxicology, seizures are an important manifestation of drug or chemical toxicity and are commonly generalized tonic-clonic.

Prolonged or recurrent seizures can cause severe complications including hypoxia, hyperthermia, metabolic acidosis, rhabdomyolysis, aspiration, brain injury, and death.

Pathophysiology

Toxicants can provoke seizures through several mechanisms, including:

• Reduced inhibitory GABA activity
• Excess excitatory neurotransmission
• Sodium-channel effects
• Excess catecholaminergic activity
• Metabolic abnormalities
• Hypoglycemia
• Hypoxia
• Electrolyte disturbances

Some poisonings produce seizures through a highly specific mechanism.

For example:

Isoniazid → pyridoxine depletion → impaired GABA synthesis → severe seizures

Risk Factors

The likelihood of seizures may be increased by:

• Pre-existing epilepsy
• Previous CNS injury
• Large toxic exposure
• Multiple proconvulsant drugs
• Hypoglycemia
• Hypoxia
• Electrolyte abnormalities
• Withdrawal from alcohol or sedative-hypnotic drugs

A seizure in pregnancy requires urgent evaluation for eclampsia and other obstetric causes, even when toxic exposure is also possible.

Important Toxicologic Causes

Tricyclic Antidepressants

TCA poisoning can produce:

• Seizures
• Altered mental status
• Anticholinergic findings
• Tachycardia
• Hypotension
• QRS widening
• Ventricular dysrhythmias

TCA-associated seizures plus QRS widening strongly suggest clinically important sodium-channel blockade.

Sodium bicarbonate is indicated when significant sodium-channel cardiotoxicity is present.

Bupropion

Bupropion is an important cause of drug-induced seizures.

Features may include:

• Agitation
• Tremor
• Tachycardia
• Seizures
• Altered mental status

Severe poisoning may cause:

• Recurrent seizures
• QRS or QT abnormalities
• Ventricular dysrhythmias
• Cardiogenic shock

Extended-release preparations can produce substantially delayed seizures, so an initially asymptomatic patient may still require prolonged observation after a significant exposure.

Isoniazid

Isoniazid is particularly important because seizures may be:

• Severe
• Recurrent
• Resistant to conventional anticonvulsant therapy

Mechanism:

Isoniazid → functional pyridoxine deficiency → decreased GABA synthesis → seizures

Associated findings may include:

• High-anion-gap metabolic acidosis
• Altered mental status
• Coma

Pyridoxine (vitamin B6) is the specific antidotal therapy.

Theophylline

Theophylline toxicity may produce:

• Nausea/vomiting
• Tremor
• Marked tachycardia
• Hypokalemia
• Hyperglycemia
• Dysrhythmias
• Seizures

Seizures may be severe and difficult to control.

Unlike many poisonings, significant theophylline toxicity may cause seizures without a prolonged warning period.

Stimulants

Examples include:

• Cocaine
• Amphetamines
• Methamphetamine
• Other sympathomimetics

Typical findings include:

• Agitation
• Mydriasis
• Diaphoresis
• Tachycardia
• Hypertension
• Hyperthermia

Severe poisoning may progress to:

• Seizures
• Dysrhythmias
• Rhabdomyolysis
• Metabolic acidosis
• Cardiovascular collapse

Antihistamines and Anticholinergic Drugs

First-generation antihistamines and other antimuscarinic agents can produce:

• Agitated delirium
• Mydriasis
• Dry mucous membranes
• Tachycardia
• Urinary retention
• Reduced bowel sounds
• Hyperthermia
• Seizures

Some antihistamines, particularly in severe overdose, can also produce sodium-channel blockade with QRS widening.

Camphor

Camphor exposure is an important cause of rapid-onset seizures, particularly in young children.

Manifestations may include:

• Nausea/vomiting
• Agitation
• Confusion
• Seizures

Neurologic toxicity can develop rapidly.

Lithium

Severe lithium toxicity may produce:

• Coarse tremor
• Hyperreflexia
• Myoclonus
• Ataxia
• Confusion
• Seizures
• Coma

Neurologic toxicity is particularly important in chronic or acute-on-chronic poisoning.

Severe cases may require hemodialysis.

Chloroquine and Hydroxychloroquine

Severe poisoning may cause rapid:

• Seizures
• Hypotension
• Hypokalemia
• QRS widening
• Ventricular dysrhythmias
• Cardiovascular collapse

Neurologic and cardiovascular deterioration can occur quickly.

Local Anesthetic Systemic Toxicity

Systemic local anesthetic toxicity may initially cause neurologic symptoms such as:

• Perioral numbness
• Metallic taste
• Tinnitus
• Agitation
• Tremor

This can progress to:

• Seizures
• CNS depression
• Dysrhythmias
• Cardiovascular collapse

Intravenous lipid emulsion is an important therapy for severe local anesthetic systemic toxicity, particularly when cardiovascular toxicity develops.

Carbon Monoxide

Severe carbon monoxide poisoning can cause:

• Headache
• Nausea
• Dizziness
• Confusion
• Syncope
• Seizures
• Coma

Multiple people developing similar symptoms in the same environment is an important clue.

A normal conventional pulse oximetry reading does not exclude carbon monoxide poisoning.

Hypoglycemic Agents

Insulin and insulin-secretagogue medications can cause neuroglycopenia.

Clinical findings include:

• Sweating
• Confusion
• Behavioral abnormalities
• Weakness
• Seizures
• Coma

Blood glucose should be checked immediately in any patient with an unexplained seizure.

Organophosphate and Carbamate Poisoning

Severe cholinergic poisoning may cause seizures.

Associated findings include:

• Miosis
• Salivation
• Lacrimation
• Bronchorrhea
• Bronchospasm
• Vomiting
• Diarrhea
• Sweating
• Bradycardia
• Fasciculations
• Weakness

Seizures may accompany severe CNS toxicity.

Treatment of significant organophosphate poisoning includes:

• Airway and ventilatory support
• Atropine
• Pralidoxime
• Benzodiazepines for seizures

Salicylates

Seizures are a late and concerning manifestation of severe salicylate poisoning.

Other findings include:

• Tachypnea
• Tinnitus
• Nausea/vomiting
• Diaphoresis
• Respiratory alkalosis
• High-anion-gap metabolic acidosis
• Hyperthermia
• Altered mental status

Seizures suggest severe toxicity and may accompany worsening CNS dysfunction.

Withdrawal Syndromes

Withdrawal from CNS depressants can provoke seizures.

Important causes include:

• Ethanol withdrawal
• Benzodiazepine withdrawal
• Barbiturate withdrawal

Associated findings may include:

• Tremor
• Agitation
• Tachycardia
• Hypertension
• Diaphoresis
• Hallucinations
• Hyperthermia

Benzodiazepines are central to treatment of severe alcohol or sedative-hypnotic withdrawal.

Strychnine: An Important Seizure Mimic

Strychnine causes severe painful muscular spasms rather than true epileptic seizures.

Typical findings include:

• Stimulus-induced muscle spasms
• Generalized rigidity
• Opisthotonus
• Preserved consciousness between or during early spasms

This distinction can help differentiate strychnine poisoning from generalized tonic-clonic seizures.

Nontoxicologic Differential Diagnosis

Not every seizure in a poisoned or potentially poisoned patient is caused by a toxicant.

Important alternative causes include:

Metabolic

• Hypoglycemia
• Hyponatremia
• Hypocalcemia
• Hypomagnesemia
• Uremia
• Hypoxia

Structural CNS Disease

• Intracranial hemorrhage
• Ischemic stroke
• Traumatic brain injury
• Brain tumor
• Cerebral edema

Infection

• Meningitis
• Encephalitis
• Brain abscess

Other

• Epilepsy
• Eclampsia
• Alcohol/sedative withdrawal

Psychogenic nonepileptic seizures can also mimic epilepsy, but should not be diagnosed merely from one historical or examination feature; video-EEG confirmation is the diagnostic standard when uncertainty persists.

Clinical Clues to the Toxicant

Tachycardia + Hypertension + Hyperthermia

Consider:

• Cocaine
• Amphetamines
• Other sympathomimetics
• MAOI toxicity
• Serotonin syndrome
• Severe withdrawal

Tachycardia + Hypotension

Consider:

• TCA poisoning
• Theophylline
• Chloroquine/hydroxychloroquine
• Other severe cardiotoxic poisoning

Bradycardia + Hypotension

Consider:

• Beta-blockers
• Organophosphates
• Carbamates
• Other cardiodepressant agents

Dry Skin + Mydriasis + Tachycardia

Suggests an anticholinergic toxidrome.

Potential causes include:

• First-generation antihistamines
• Antimuscarinic medications
• TCAs

Miosis + Secretions

Miosis accompanied by:

• Salivation
• Bronchorrhea
• Diarrhea
• Sweating
• Fasciculations

strongly suggests a cholinergic syndrome.

Nystagmus

May occur with:

• PCP
• Carbamazepine
• Certain anticonvulsants
• Sedative/intoxicating agents

Rigidity + Hyperthermia

Consider:

• Serotonin syndrome
• Neuroleptic malignant syndrome
• MAOI-related toxicity
• Malignant hyperthermia in the appropriate peri-anesthetic setting

Clonus and hyperreflexia favor serotonin syndrome.

Severe generalized rigidity with a slower onset favors NMS.

Complications of Prolonged Seizures

Prolonged or recurrent seizures can produce:

• Hypoxemia
• Hypercapnia
• Lactic acidosis
• Hyperthermia
• Rhabdomyolysis
• Hyperkalemia
• Acute kidney injury
• Aspiration
• Brain injury
• Cardiovascular instability

A transient lactate elevation and high-anion-gap metabolic acidosis can occur after a generalized tonic-clonic seizure and often improve as the seizure-related lactate clears.

Persistent severe acidosis should prompt investigation for another cause.

Initial Evaluation

Immediate priorities are:

Airway → breathing → circulation → stop seizure → identify reversible causes

Assess:

• Airway protection
• Ventilation
• Oxygenation
• Heart rate and rhythm
• Blood pressure
• Temperature
• Neurologic status

Obtain a rapid bedside glucose immediately.

Laboratory Evaluation

Important investigations may include:

• Glucose
• Electrolytes
• Calcium
• Magnesium
• Bicarbonate
• BUN and creatinine
• Blood gas
• Lactate
• CK

Depending on the exposure, obtain targeted testing such as:

• Salicylate concentration
• Acetaminophen concentration
• Lithium concentration
• Theophylline concentration
• Carbon monoxide testing
• Anticonvulsant concentrations

Broad urine drug screens have important limitations and should not replace toxidrome-based assessment.

ECG

An ECG is essential when toxicant-induced seizure is suspected.

Look for:

• QRS widening
• QT prolongation
• Bradycardia
• AV block
• Ventricular dysrhythmias

Seizure + QRS widening should particularly raise concern for a sodium-channel-blocking drug such as a TCA or certain antihistamines.

Neuroimaging and Lumbar Puncture

Head CT or other neuroimaging should be considered when there is concern for:

• Trauma
• Intracranial hemorrhage
• Focal neurologic deficit
• Structural CNS disease
• Unexplained persistent altered mental status

Lumbar puncture may be required when CNS infection or another appropriate neurologic diagnosis is suspected.

Management of Toxicant-Induced Seizures

First-Line: Benzodiazepines

Benzodiazepines are the preferred initial treatment for most toxicant-induced seizures.

They enhance GABA-mediated inhibition and are particularly useful because many toxic seizures result from excessive CNS excitation.

Examples include:

• Lorazepam
• Diazepam
• Midazolam

Repeated treatment may be necessary for recurrent seizures.

Persistent or Refractory Seizures

If seizures continue despite adequate benzodiazepine therapy, escalation may include:

• Additional GABAergic antiseizure therapy
• Airway control and mechanical ventilation when necessary
• Continuous EEG monitoring
• Specialist toxicology and critical-care management

Phenobarbital is an important second-line option for many toxin-induced refractory seizures.

Severe refractory status epilepticus may require anesthetic therapy in an ICU.

Role of Phenytoin

Phenytoin is generally less useful for many toxicant-induced seizures because it does not correct the mechanisms responsible for many poison-induced convulsions.

In particular, it should not be considered the preferred treatment for seizures caused by:

• Isoniazid
• Theophylline
• Withdrawal
• Many stimulant poisonings

Treatment should instead emphasize benzodiazepines and toxin-specific therapy.

Isoniazid-Induced Seizures

Isoniazid poisoning is a major exception requiring specific antidotal therapy.

Pyridoxine (vitamin B6) should be administered when isoniazid toxicity is strongly suspected, particularly with refractory seizures.

Benzodiazepines are used concurrently.

Failure to recognize isoniazid toxicity can result in persistent seizures despite conventional anticonvulsant therapy.

Neuromuscular Paralysis

Neuromuscular blocking agents may stop visible muscular activity but do not stop cerebral seizure activity.

Therefore, if paralysis is required for airway management or severe refractory convulsive activity:

Continuous EEG monitoring is important when ongoing seizure activity remains possible.

Paralysis must never be mistaken for successful treatment of the underlying seizure.

Airway Management

Endotracheal intubation may be necessary when there is:

• Persistent status epilepticus
• Severe respiratory depression
• Recurrent seizures with inadequate ventilation
• Severe aspiration risk
• Inability to protect the airway
• Need for deep sedation or anesthetic therapy

Airway management should occur alongside treatment of the seizure rather than delaying anticonvulsant therapy.

Decontamination

Do not induce vomiting.

Routine gastric lavage is generally not recommended.

Activated charcoal may be considered only in selected recent, serious, adsorbable ingestions when the airway is adequately protected.

A patient who is actively seizing or has markedly impaired consciousness has a major aspiration risk, so gastrointestinal decontamination should never take priority over stabilization.

Monitoring

Patients with significant toxicant-induced seizures should be monitored for:

• Recurrent seizures
• Respiratory depression
• Oxygenation and ventilation
• Dysrhythmias
• Hypotension
• Hyperthermia
• Rhabdomyolysis
• Electrolyte abnormalities
• Acute kidney injury

Continuous cardiac monitoring is appropriate in significant poisoning.

Continuous EEG may be required for refractory seizures, persistent unexplained coma, or patients receiving neuromuscular blockade.

Key Points

• Toxicant-induced seizures are commonly generalized tonic-clonic seizures.
• Important mechanisms include reduced GABA activity, excessive excitatory neurotransmission, metabolic abnormalities, hypoglycemia, and hypoxia.
• Common toxicologic causes include bupropion, TCAs, antihistamines, stimulants, isoniazid, theophylline, lithium, camphor, salicylates, and withdrawal syndromes.
• Always check bedside glucose immediately in an unexplained seizure.
• Obtain an ECG, because seizures may accompany life-threatening cardiotoxic poisoning.
• Seizure + QRS widening suggests possible sodium-channel-blocker toxicity.
• Isoniazid should be considered when seizures are unusually refractory, especially with compatible exposure history and metabolic acidosis.
• Pyridoxine is the specific antidotal therapy for isoniazid-induced seizures.
• Benzodiazepines are first-line treatment for most toxicant-induced seizures.
• Phenobarbital or other GABAergic therapy may be required for refractory seizures.
• Phenytoin is generally less effective for many toxin-induced seizures and is not the preferred universal second-line therapy.
• Neuromuscular paralysis eliminates visible convulsions but does not terminate cerebral seizure activity.
• Prolonged seizures can cause hyperthermia, lactic acidosis, rhabdomyolysis, hypoxia, aspiration, and brain injury.
• Always evaluate for nontoxicologic causes, including metabolic abnormalities, CNS infection, structural brain disease, epilepsy, and eclampsia.

Toxicology – Pulmonary Edema

Definition

Pulmonary edema is the abnormal accumulation of fluid within the pulmonary interstitium and alveolar spaces.

As fluid accumulates, it interferes with:

• Oxygen diffusion
• Alveolar ventilation
• Lung compliance
• Normal gas exchange

Progressive pulmonary edema can therefore cause hypoxemia and acute respiratory failure.

Classification

Pulmonary edema is broadly divided into:

• Cardiogenic pulmonary edema
• Noncardiogenic pulmonary edema

Most toxicologic causes are noncardiogenic, although toxins that cause severe myocardial depression can produce cardiogenic edema.

Cardiogenic Pulmonary Edema

Cardiogenic pulmonary edema results from elevated pulmonary hydrostatic pressure, usually secondary to left-sided cardiac dysfunction.

Typical sequence:

Left ventricular dysfunction → increased left atrial pressure → increased pulmonary venous/capillary pressure → fluid movement into interstitium and alveoli

Potential mechanisms include:

• Impaired LV systolic function
• Severe diastolic dysfunction
• Acute valvular dysfunction
• Myocardial ischemia
• Severe hypertension
• Toxin-induced myocardial depression

Noncardiogenic Pulmonary Edema

Noncardiogenic pulmonary edema results primarily from increased permeability of the alveolar-capillary barrier, rather than elevated left-sided cardiac pressure.

This may occur following:

• Direct inhalational lung injury
• Aspiration
• Severe systemic poisoning
• Systemic inflammatory response
• Acute respiratory distress syndrome (ARDS)

Mechanism:

Alveolar-capillary injury → increased permeability → protein-rich fluid enters interstitium/alveoli → impaired gas exchange

Toxicologic Causes

Opioids

Opioid poisoning may be associated with noncardiogenic pulmonary edema.

Typical opioid findings include:

• CNS depression
• Bradypnea
• Hypoventilation
• Miosis

Pulmonary edema may manifest with:

• Hypoxemia
• Crackles
• Frothy airway secretions
• Bilateral pulmonary infiltrates

The immediate priority remains restoration of adequate ventilation.

Naloxone reverses opioid-induced respiratory depression, but pulmonary edema may occasionally be recognized or develop around the time of reversal; this should not prevent appropriate naloxone use when ventilation is impaired.

Salicylates

Severe salicylate poisoning can cause noncardiogenic pulmonary edema, particularly in older adults and patients with significant systemic toxicity.

Associated findings include:

• Tachypnea
• Tinnitus
• Nausea/vomiting
• Diaphoresis
• Respiratory alkalosis
• High-anion-gap metabolic acidosis
• Altered mental status

Pulmonary edema in salicylate poisoning indicates potentially severe toxicity.

Stimulants

Cocaine and amphetamine-type stimulants can produce pulmonary complications.

Associated systemic findings may include:

• Agitation
• Tachycardia
• Hypertension
• Hyperthermia
• Seizures
• Dysrhythmias

Pulmonary injury may result from several mechanisms, including direct lung injury, inflammation, ischemia, aspiration, or cardiac dysfunction.

Hydrocarbon Aspiration

Aspiration of low-viscosity hydrocarbons can produce chemical pneumonitis and potentially severe pulmonary injury.

Clinical progression may include:

Aspiration → coughing/choking → inflammatory lung injury → worsening hypoxemia

Findings include:

• Persistent cough
• Tachypnea
• Dyspnea
• Hypoxemia
• Fever
• Crackles

Pulmonary abnormalities can worsen over several hours.

Irritant Gas Inhalation

Important inhaled pulmonary toxicants include:

• Chlorine
• Chloramine
• Ammonia
• Phosgene
• Nitrogen dioxide
• Ozone
• Hydrogen chloride
• Acrolein
• Isocyanates
• Smoke products

These substances can injure the respiratory epithelium and alveolar-capillary membrane.

Water Solubility and Symptom Timing

Highly water-soluble gases tend to cause early upper-airway and mucosal irritation.

Examples include:

• Ammonia
• Hydrogen chloride

Poorly water-soluble gases can penetrate more deeply into the lungs and may produce delayed pulmonary injury.

Classic examples include:

• Phosgene
• Nitrogen dioxide

Therefore:

An initially reassuring examination does not always exclude serious inhalational lung injury.

Phosgene

Phosgene is a classic cause of delayed noncardiogenic pulmonary edema.

Early symptoms may be relatively mild:

• Cough
• Throat irritation
• Chest discomfort

After a latent period, patients may develop:

• Increasing dyspnea
• Tachypnea
• Hypoxemia
• Crackles
• Pulmonary edema

Delayed deterioration is an important diagnostic feature.

Organophosphate and Carbamate Poisoning

These poisonings can cause severe respiratory compromise, but pulmonary secretions should be distinguished from true pulmonary edema.

Muscarinic excess produces:

• Bronchorrhea
• Bronchospasm
• Salivation
• Lacrimation
• Miosis
• Vomiting
• Diarrhea
• Bradycardia

Nicotinic toxicity may produce:

• Fasciculations
• Weakness
• Respiratory muscle paralysis

Respiratory failure may therefore result from a combination of:

Bronchorrhea + bronchospasm + respiratory muscle weakness + CNS effects

Tricyclic Antidepressants

Severe TCA poisoning can occasionally be complicated by pulmonary edema.

More characteristic manifestations include:

• Altered mental status
• Anticholinergic findings
• Seizures
• QRS widening
• Hypotension
• Ventricular dysrhythmias

Cardiovascular instability results primarily from sodium-channel blockade and myocardial toxicity.

Cardiotoxic Drugs

Beta-Blockers and Calcium Channel Blockers

Severe poisoning can produce:

• Bradycardia
• AV block
• Myocardial depression
• Hypotension
• Cardiogenic shock

Marked myocardial dysfunction may consequently cause cardiogenic pulmonary edema.

Colchicine

Severe colchicine poisoning causes multisystem toxicity.

Early manifestations often include:

• Nausea
• Vomiting
• Abdominal pain
• Diarrhea

Severe poisoning may progress to:

• Myocardial dysfunction
• Shock
• Respiratory failure
• Multiorgan failure

Pulmonary edema may occur as part of severe cardiopulmonary toxicity.

Other Causes

Important nontoxicologic causes include:

• Acute heart failure
• Myocardial infarction
• Cardiomyopathy
• Myocarditis
• Severe hypertension
• Acute valvular disease
• Sepsis
• Severe trauma
• Burns
• Aspiration of gastric contents
• ARDS

These conditions should remain in the differential even when poisoning is suspected.

Clinical Features

The primary consequence of pulmonary edema is impaired oxygenation.

Common manifestations include:

• Dyspnea
• Tachypnea
• Increased work of breathing
• Cough
• Hypoxemia
• Chest discomfort
• Orthopnea, particularly in cardiogenic edema
• Restlessness or anxiety

Severe disease may produce:

• Cyanosis
• Frothy sputum
• Respiratory fatigue
• Hypercapnia
• Altered mental status
• Respiratory failure

Pulmonary Examination

Early disease may present with only:

• Tachypnea
• Mild hypoxemia

As pulmonary fluid increases:

• Crackles may develop.
• Wheezing may occur.
• Breath sounds may become abnormal.
• Work of breathing increases.

Auscultatory findings alone do not reliably distinguish cardiogenic from noncardiogenic edema.

Cardiogenic Clinical Clues

Features supporting cardiogenic pulmonary edema include:

• Known cardiac disease
• Elevated jugular venous pressure
• Peripheral edema
• S3 gallop
• Orthopnea
• Evidence of myocardial dysfunction
• Cardiomegaly
• Pleural effusions

However, none of these findings alone is completely diagnostic.

Noncardiogenic Clinical Clues

Noncardiogenic edema is more likely when there is:

• A compatible toxic exposure
• Aspiration
• Sepsis or systemic inflammation
• Inhalational injury
• Bilateral pulmonary infiltrates without clear evidence of left-sided heart failure

Modern evaluation often uses bedside echocardiography and lung ultrasound together with the overall clinical picture.

Diagnostic Evaluation

Pulse Oximetry

Pulse oximetry provides continuous assessment of oxygen saturation.

Persistent or worsening hypoxemia indicates significant pulmonary dysfunction.

However, pulse oximetry does not measure ventilation and may not identify hypercapnia.

Blood Gas Analysis

Blood gas testing may be useful in severe respiratory distress.

Possible findings include:

• Hypoxemia
• Hypercapnia with ventilatory failure
• Respiratory alkalosis early in some conditions
• Metabolic acidosis from the underlying poisoning

Chest Imaging

Chest radiography can support the diagnosis but may be normal early, particularly after certain inhalational exposures.

Cardiogenic Edema

Possible findings include:

• Bilateral perihilar opacities
• Vascular redistribution
• Interstitial edema
• Kerley B lines
• Cardiomegaly
• Pleural effusions

Noncardiogenic Edema

Possible findings include:

• Bilateral diffuse or patchy opacities
• Alveolar infiltrates
• Normal cardiac silhouette

Imaging findings overlap considerably, so chest radiography should not be interpreted in isolation.

Bedside Ultrasound

Lung ultrasound may demonstrate diffuse B-lines, supporting the presence of interstitial/alveolar fluid.

Focused cardiac ultrasound can assess:

• Ventricular function
• Gross volume status
• Pericardial abnormalities
• Evidence supporting cardiogenic shock

This is often more practical than invasive hemodynamic monitoring.

ECG

An ECG is particularly important when pulmonary edema may result from:

• Myocardial ischemia
• TCA poisoning
• Beta-blocker poisoning
• Calcium channel blocker poisoning
• Stimulant toxicity
• Other cardiotoxic agents

Evaluate for:

• Ischemia
• Bradycardia
• AV block
• QRS widening
• QT abnormalities
• Dysrhythmias

Laboratory Evaluation

Testing should be directed toward the suspected cause.

Possible investigations include:

• Electrolytes
• Glucose
• Renal function
• Blood gas
• Lactate
• Cardiac biomarkers when indicated
• CBC
• CK when rhabdomyolysis is suspected

Targeted toxicology testing may include:

• Salicylate concentration
• Acetaminophen concentration when relevant
• Specific drug concentrations when clinically useful

Broad urine drug screening has important limitations and should not replace clinical assessment.

Management

The major priorities are:

Correct hypoxemia → support ventilation → identify and treat the underlying toxicant

Management depends on the severity and mechanism of pulmonary edema.

Airway and Oxygenation

Provide supplemental oxygen when hypoxemia is present.

Patients with significant respiratory distress may benefit from positive-pressure ventilatory support, depending on clinical circumstances.

Endotracheal intubation and mechanical ventilation may be necessary when there is:

• Severe refractory hypoxemia
• Progressive respiratory fatigue
• Inadequate ventilation
• Severe CNS depression
• Inability to protect the airway

Fluid Management

Fluid administration should be individualized.

Excessive IV fluid can worsen pulmonary edema.

However, toxicologic patients may simultaneously have:

• Hypotension
• Vasodilation
• Dehydration
• Cardiogenic shock

Therefore, hypotension should not automatically trigger large-volume fluid administration.

When fluids are appropriate, use careful reassessment after limited administration.

Persistent shock may require early vasopressor therapy and treatment of the specific poisoning.

Cardiogenic Pulmonary Edema

Treatment should address the underlying cardiac problem.

Depending on blood pressure and volume status, therapy may include:

• Oxygen/ventilatory support
• Positive-pressure ventilation
• Nitrates when appropriate
• Diuretics when volume overload is present
• Treatment of myocardial ischemia
• Treatment of dysrhythmias
• Toxin-specific cardiovascular therapy

The older routine use of morphine for cardiogenic pulmonary edema is no longer recommended because benefit has not been established and respiratory depression or hypotension may occur.

Noncardiogenic Pulmonary Edema

Management is primarily supportive and directed toward the cause.

Possible interventions include:

• Oxygen
• Appropriate positive-pressure ventilation
• Lung-protective mechanical ventilation when ARDS develops
• Careful fluid management
• Treatment of the causative poisoning
• Treatment of associated shock

Routine diuresis is not automatically indicated simply because pulmonary edema is present; volume status and mechanism should guide therapy.

Toxin-Specific Treatment

Examples include:

• Opioids → naloxone when respiratory depression is present
• Salicylates → alkalinization and hemodialysis when indicated
• TCA sodium-channel toxicity → sodium bicarbonate
• Organophosphates → atropine + pralidoxime when indicated
• Beta-blocker/CCB toxicity → toxin-specific cardiovascular support

The pulmonary edema itself does not replace treatment of the underlying poisoning.

Decontamination

Induced vomiting is not recommended.

Routine gastric lavage is generally not recommended, particularly in patients with:

• Respiratory distress
• Altered mental status
• Aspiration risk
• Unprotected airway

Activated charcoal may be considered only for selected recent, serious, adsorbable ingestions when the airway is adequately protected.

In pulmonary edema, preventing further aspiration is especially important.

Monitoring

Patients with clinically significant pulmonary edema require close monitoring of:

• Respiratory rate
• Work of breathing
• Oxygen saturation
• Mental status
• Blood pressure
• Heart rate and rhythm
• Urine output when critically ill

Serial evaluation may include:

• Blood gases
• Electrolytes
• Renal function
• Chest imaging
• Bedside ultrasound

Delayed Pulmonary Edema

Some inhaled toxicants can cause significant pulmonary injury hours after exposure.

Particularly important examples include:

• Phosgene
• Nitrogen dioxide
• Certain other poorly water-soluble irritant gases

Therefore:

Normal initial examination or chest radiograph does not always exclude later respiratory deterioration.

Observation should be based on the specific exposure and clinical findings.

Prognosis

Outcome depends primarily on:

• Underlying toxicant
• Severity of hypoxemia
• Degree of lung injury
• Cardiovascular involvement
• Duration before treatment
• Development of ARDS or multiorgan failure

Many toxicologic causes improve with appropriate supportive and toxin-specific treatment.

Severe lung injury can result in prolonged respiratory failure and, occasionally, persistent pulmonary dysfunction.

Key Points

• Pulmonary edema is fluid accumulation within the pulmonary interstitium and alveoli, causing impaired gas exchange.
• It is classified as cardiogenic or noncardiogenic.
• Cardiogenic edema results primarily from increased pulmonary hydrostatic pressure.
• Noncardiogenic edema results primarily from increased alveolar-capillary permeability.
• Most toxicologic causes are noncardiogenic.
• Important toxicologic causes include opioids, salicylates, stimulants, hydrocarbon aspiration, irritant gases, and severe systemic poisonings.
• Beta-blockers, calcium channel blockers, and other cardiotoxic agents may cause cardiogenic pulmonary edema through myocardial depression.
• Organophosphate poisoning causes prominent bronchorrhea and respiratory muscle dysfunction, which may mimic or coexist with pulmonary edema.
• Phosgene and other poorly water-soluble inhalants may cause delayed pulmonary injury.
• Chest radiography can be normal early.
• Management prioritizes oxygenation, ventilation, careful fluid management, and treatment of the underlying poisoning.
• Routine morphine is not recommended for cardiogenic pulmonary edema.
• Diuretics are appropriate when clinically indicated by cardiogenic congestion or volume overload, but are not routine therapy for all toxicologic pulmonary edema.
• Excessive IV fluid administration can worsen pulmonary edema.
• Significant respiratory failure may require positive-pressure ventilation or endotracheal intubation.

Toxicology – Peripheral Neuropathy

Definition

Peripheral neuropathy is dysfunction or injury involving the peripheral nervous system, producing abnormalities of:

• Sensory function
• Motor function
• Autonomic function

Toxic peripheral neuropathies are commonly symmetric polyneuropathies affecting the distal extremities first.

A typical pattern is:

Distal sensory symptoms → progressive proximal involvement → possible motor weakness and reflex loss

Clinical Pattern

Sensory Symptoms

Sensory abnormalities commonly include:

• Tingling
• Prickling
• Burning
• Numbness
• Stinging sensations
• Neuropathic pain
• Reduced sensation

Symptoms usually begin distally in the feet and toes, although some toxic neuropathies may initially involve the hands.

As the neuropathy progresses, symptoms extend proximally.

The classic distribution is described as:

“Stocking-glove” sensory loss

Lower-extremity involvement usually becomes more prominent than upper-extremity involvement.

Motor Symptoms

Motor neuropathy may produce:

• Distal weakness
• Difficulty walking
• Foot drop
• Wrist drop
• Reduced grip strength
• Muscle wasting in chronic cases

Weakness commonly progresses:

Distal → proximal

Deep tendon reflexes may become reduced and severe polyneuropathy can produce generalized areflexia.

Autonomic Neuropathy

Peripheral autonomic nerve involvement can produce:

• Orthostatic hypotension
• Abnormal sweating
• Gastrointestinal dysmotility
• Urinary dysfunction
• Sexual dysfunction
• Abnormal heart-rate responses

Autonomic abnormalities may accompany sensory or motor neuropathy depending on the underlying toxicant.

Pathophysiologic Classification

Toxic neuropathies can be classified according to the portion of the peripheral nerve that is primarily injured.

Axonopathy

Axonopathy refers to damage primarily involving the nerve axon.

It is one of the most common patterns of toxic peripheral neuropathy.

Long axons are particularly vulnerable, producing a length-dependent neuropathy.

Therefore:

Longest nerves affected first → feet before hands → distal before proximal

Recovery can be slow because damaged axons must regenerate.

Neuronopathy

Neuronopathy involves injury to the nerve-cell body.

Depending on the affected neurons, injury may involve:

• Anterior horn cells → motor dysfunction
• Dorsal root ganglia → sensory dysfunction
• Autonomic neurons → autonomic dysfunction

Sensory neuronopathy may produce a pattern that is less strictly length-dependent than typical distal axonopathy.

Myelinopathy

Myelinopathy results from injury to the myelin sheath surrounding peripheral nerves.

Large myelinated fibers may be particularly affected.

Clinical manifestations can include impaired:

• Vibration sensation
• Proprioception
• Light touch
• Motor conduction
• Reflexes

Electrodiagnostic testing can help distinguish demyelination from primary axonal injury.

Mononeuropathy

Mononeuropathy involves one individual peripheral nerve.

Examples include isolated dysfunction of the:

• Median nerve
• Ulnar nerve
• Radial nerve
• Peroneal nerve

Compression and traumatic injury are common nontoxic causes.

Polyneuropathy

Polyneuropathy involves multiple peripheral nerves.

Most toxic neuropathies are:

• Diffuse
• Bilateral
• Relatively symmetric
• Distal-predominant

This pattern is an important clue to systemic toxic, metabolic, nutritional, or medication-related disease.

Toxic Causes of Predominantly Sensory Neuropathy

Important agents include:

• Cisplatin
• Taxanes
• Pyridoxine excess
• Nitrous oxide
• Colchicine
• Some antiretroviral medications
• Selected antimicrobial agents

Symptoms may include:

• Paresthesias
• Numbness
• Burning pain
• Loss of vibration
• Impaired proprioception

Nitrous Oxide

Repeated or substantial nitrous oxide exposure can produce neurologic dysfunction by functionally inactivating vitamin B12.

This interferes with methionine synthase and normal myelin metabolism.

Clinical manifestations may include:

• Paresthesias
• Sensory loss
• Gait abnormalities
• Weakness
• Impaired proprioception
• Ataxia

Neurologic toxicity can occur even when the measured serum vitamin B12 concentration is not dramatically reduced.

Toxic Causes of Combined Sensory and Motor Neuropathy

Important causes include:

• Arsenic
• Thallium
• Lead
• Chronic ethanol exposure
• Isoniazid
• Metronidazole
• Nitrofurantoin
• Phenytoin
• Vincristine
• Carbon disulfide
• Acrylamide
• n-Hexane
• Certain organophosphates
• Amiodarone

The exact pattern depends on the toxicant and duration of exposure.

Arsenic

Acute or chronic arsenic exposure can produce a painful sensorimotor peripheral neuropathy.

Neurologic findings may include:

• Painful paresthesias
• Numbness
• Weakness
• Reduced reflexes

Severe acute poisoning may initially cause:

• Gastrointestinal symptoms
• Hypotension
• Dysrhythmias
• Encephalopathy

Neuropathy can develop after the acute systemic illness, sometimes with delayed onset.

Chronic exposure may also produce characteristic skin and nail abnormalities.

Thallium

Thallium poisoning classically produces:

• Severe painful peripheral neuropathy
• Paresthesias
• Weakness
• Gastrointestinal symptoms
• Alopecia

A useful diagnostic combination is:

Painful neuropathy + gastrointestinal illness + delayed alopecia → consider thallium

Lead

Chronic lead exposure can produce predominantly motor neuropathy.

Classic findings include:

• Wrist drop
• Foot drop
• Extensor muscle weakness

Other manifestations may include:

• Abdominal pain
• Cognitive or neurologic abnormalities
• Anemia
• Renal abnormalities
• Hypertension

Diagnosis is based primarily on the blood lead concentration and exposure history.

Mercury

Mercury exposure can produce neurologic abnormalities, particularly after chronic exposure.

Possible findings include:

• Tremor
• Paresthesias
• Weakness
• Neuropsychiatric abnormalities

Elemental mercury vapor exposure may additionally produce:

• Gingivostomatitis
• Excessive salivation
• Respiratory injury after substantial inhalation

The clinical pattern varies considerably with the chemical form of mercury.

Isoniazid

Isoniazid can cause peripheral neuropathy by interfering with pyridoxine metabolism.

The neuropathy is typically:

• Symmetric
• Distal
• Sensory or sensorimotor

Risk is increased in patients with nutritional deficiency and other predisposing conditions.

Pyridoxine supplementation is commonly used to prevent neuropathy in patients at increased risk during isoniazid therapy.

n-Hexane

Chronic exposure to n-hexane can cause a progressive sensorimotor axonopathy.

Its neurotoxic metabolite, 2,5-hexanedione, damages peripheral nerves.

Clinical manifestations include:

• Distal paresthesias
• Weakness
• Reduced reflexes
• Progressive motor impairment

Symptoms may continue to worsen temporarily even after exposure stops.

Organophosphates

Most acute organophosphate toxicity produces a cholinergic syndrome, rather than peripheral neuropathy.

However, certain organophosphates can cause organophosphate-induced delayed neuropathy after the acute poisoning.

This may appear after a latent period and cause:

• Distal weakness
• Paresthesias
• Gait abnormalities
• Foot drop
• Progressive motor dysfunction

This delayed neuropathy is mechanistically distinct from the acute cholinergic syndrome.

Vincristine

Vincristine is an important medication-associated cause of peripheral neuropathy.

Possible manifestations include:

• Paresthesias
• Sensory loss
• Weakness
• Reduced reflexes
• Foot drop
• Autonomic dysfunction

Autonomic involvement may contribute to constipation or ileus.

Amiodarone

Chronic amiodarone exposure can occasionally produce peripheral neuropathy.

Associated toxicity may involve other organs, including:

• Thyroid
• Liver
• Lungs
• Eyes

Therefore, neuropathy in a patient receiving long-term amiodarone should be interpreted in the context of other potential medication toxicities.

Colchicine

Colchicine toxicity or chronic colchicine exposure may produce a neuromyopathy rather than an isolated peripheral neuropathy.

Features may include:

• Proximal weakness
• Sensory abnormalities
• Elevated CK
• Reduced reflexes

Risk may increase with renal dysfunction or interacting medications.

Important Nontoxic Causes

Toxic exposure is only one possible cause of peripheral neuropathy.

Common alternatives include:

• Diabetes mellitus
• Vitamin B12 deficiency
• Thiamine deficiency
• Chronic kidney disease/uremia
• Guillain-Barré syndrome
• Nerve compression or trauma
• Hypothyroidism
• Autoimmune disease
• Vasculitis
• Malignancy
• Amyloidosis
• Hereditary neuropathies
• Infections

A toxic cause should therefore not be assumed solely because neuropathy is present.

Guillain-Barré Syndrome

Guillain-Barré syndrome is an important alternative diagnosis, especially when weakness progresses rapidly.

Typical features include:

• Symmetric weakness
• Reduced or absent reflexes
• Progressive ascending involvement
• Possible cranial nerve dysfunction
• Possible respiratory muscle weakness
• Autonomic instability

CSF may demonstrate:

Elevated protein with relatively few cells

However, this finding may be absent early in the disease.

Neuromuscular Disorders That Can Mimic Neuropathy

Several disorders cause weakness without primarily damaging peripheral sensory nerves.

Important examples include:

• Myasthenia gravis
• Lambert-Eaton myasthenic syndrome
• Botulism
• Tick paralysis
• Hypokalemia
• Neuromuscular-blocking drug toxicity
• Myopathy

Careful examination helps determine whether dysfunction is primarily:

Peripheral nerve vs neuromuscular junction vs muscle vs CNS

Clinical Examination

A complete neurologic examination should assess:

Mental Status

Helps identify associated CNS involvement.

Cranial Nerves

Abnormalities may suggest an alternative or specific toxicologic diagnosis.

Motor Function

Assess:

• Strength
• Muscle bulk
• Tone
• Distribution of weakness

Sensory Function

Assess:

• Pain
• Temperature
• Light touch
• Vibration
• Proprioception

Reflexes

Reduced or absent reflexes support peripheral nerve involvement.

Coordination and Gait

Evaluate:

• Ataxia
• Balance
• Proprioceptive dysfunction
• Foot drop

Respiratory Muscle Assessment

Progressive motor neuropathy can involve respiratory muscles.

Warning findings include:

• Dyspnea
• Weak cough
• Difficulty clearing secretions
• Bulbar weakness
• Rapidly progressive generalized weakness

Serial respiratory measurements such as forced vital capacity and inspiratory pressure can help identify impending ventilatory failure.

Pulse oximetry alone may remain normal until relatively late and does not adequately assess ventilation.

Laboratory Evaluation

Testing should be guided by the suspected cause.

Possible investigations include:

• CBC
• Electrolytes
• Glucose
• Renal function
• Liver function
• Vitamin B12
• Thyroid studies
• CK

Targeted toxicologic testing may include:

• Blood lead concentration
• Arsenic testing
• Mercury testing
• Thallium testing

Testing should be based on a credible exposure history and compatible clinical syndrome rather than indiscriminate heavy-metal screening.

Electrodiagnostic Studies

Nerve conduction studies and electromyography (EMG) are useful for characterizing peripheral neuropathy.

They can help determine whether the process is predominantly:

• Axonal
• Demyelinating
• Motor
• Sensory
• Sensorimotor

They can also help distinguish neuropathy from primary muscle or neuromuscular-junction disorders.

Lumbar Puncture

Lumbar puncture is not routinely required for toxic neuropathy.

It may be useful when an alternative neurologic diagnosis is suspected, particularly Guillain-Barré syndrome.

Imaging

MRI may be appropriate when findings suggest:

• Spinal cord disease
• CNS demyelinating disease
• Tumor
• Structural neurologic disease

Imaging is generally used to investigate alternative diagnoses, rather than to confirm toxic peripheral neuropathy.

Nerve Biopsy

Nerve biopsy is rarely required for suspected toxic neuropathy.

It is invasive and generally provides limited additional information when the exposure history, neurologic examination, and electrodiagnostic studies already establish the pattern.

Management

The most important intervention in toxic peripheral neuropathy is:

Identify and discontinue or eliminate the causative exposure.

Management may include:

• Discontinuing the responsible medication when appropriate
• Removing occupational or environmental exposure
• Treating an identified nutritional deficiency
• Treating neuropathic pain
• Physical therapy
• Occupational therapy
• Mobility assistance
• Prevention of falls and injuries

Specific treatment depends on the underlying toxicant.

Decontamination

Gastrointestinal decontamination usually has no role once peripheral neuropathy has developed.

Toxic neuropathies commonly appear after enough time has passed that the original substance has already been absorbed.

The priority is therefore:

Stop ongoing exposure and prevent additional injury.

Antidotes

There is no universal antidote for toxic peripheral neuropathy.

Some underlying poisonings have specific treatments, but these treatments address the toxic exposure rather than directly reversing established nerve damage.

Examples include:

• Chelation for selected confirmed heavy-metal poisonings
• Pyridoxine for appropriate isoniazid-related problems
• Prussian blue for thallium poisoning

Treatment should be directed toward the specific toxicant.

Prognosis

Recovery depends on:

• Toxicant involved
• Severity of nerve injury
• Axonal versus demyelinating injury
• Duration of exposure
• Speed of exposure removal
• Presence of underlying neurologic disease

Neurologic abnormalities may continue to worsen for days or even weeks after exposure stops.

This phenomenon does not necessarily indicate continued exposure.

Axonal regeneration is slow, so recovery may take:

• Weeks
• Months
• Occasionally longer

Some patients recover completely, while others retain residual sensory or motor deficits.

Key Points

• Peripheral neuropathy causes sensory, motor, and/or autonomic dysfunction of peripheral nerves.
• Most toxic neuropathies are symmetric, distal polyneuropathies.
• Axonopathy is a common mechanism of toxic neuropathy.
• Length-dependent axonal injury typically affects the feet before the hands.
• Sensory symptoms include paresthesias, burning pain, numbness, and impaired sensation.
• Motor involvement causes distal weakness, foot drop, wrist drop, muscle wasting, and reduced reflexes.
• Important toxic causes include arsenic, thallium, lead, mercury, isoniazid, nitrous oxide, n-hexane, vincristine, metronidazole, certain organophosphates, and several medications.
• Painful neuropathy followed by alopecia is an important clue to thallium poisoning.
• Wrist or foot drop is classically associated with lead neuropathy.
• Nitrous oxide can produce neurologic dysfunction through functional vitamin B12 inactivation.
• Some organophosphates can produce a delayed neuropathy after the acute cholinergic syndrome has resolved.
• Electrodiagnostic studies help distinguish axonal from demyelinating neuropathy.
• Rapidly progressive weakness requires assessment for respiratory muscle involvement.
• Always consider common nontoxic causes such as diabetes, vitamin deficiencies, uremia, Guillain-Barré syndrome, and nerve compression.
• Treatment centers on removing the causative exposure, treating the specific poisoning when possible, controlling neuropathic symptoms, and rehabilitation.
• Neuropathy may temporarily continue to worsen after exposure stops, and neurologic recovery can require weeks to months.

Toxicology – Osmolal Gap

Definition

The osmolal gap is the difference between the measured serum osmolality and the calculated serum osmolality.

It is primarily used in toxicology as a screening clue for the presence of unmeasured, osmotically active substances, particularly toxic alcohols.

The terms:

• Osmolal gap
• Osmolar gap
• Osmol gap

are often used interchangeably clinically, although osmolal gap is technically the preferred term when serum osmolality is measured.

⸻

Calculation

A commonly used calculated serum osmolality equation is:

Calculated serum osmolality ≈ 2 × Na + glucose/18 + BUN/2.8

when glucose and BUN are reported in mg/dL.

If ethanol is known to be present, some clinical formulas incorporate its osmotic contribution when interpreting the residual gap.

⸻

Normal Osmolal Gap

A value around −10 to +10 mOsm/kg is commonly considered within the expected range, although the reference interval depends on:

• Laboratory method
• Calculation formula
• Individual baseline
• Whether ethanol is included in the calculation

Therefore, a rigid cutoff should not be used to exclude poisoning.

⸻

Clinical Significance

An elevated osmolal gap indicates the presence of unmeasured osmotically active substances.

Important toxicologic causes include:

• Methanol
• Ethylene glycol
• Isopropanol
• Ethanol
• Propylene glycol
• Acetone

Other causes include:

• Mannitol
• Ketoacidosis
• Renal failure
• Shock or critical illness
• Some other endogenous or administered osmoles

An elevated gap is therefore not specific for toxic alcohol poisoning.

⸻

Pathophysiology

Measured serum osmolality reflects the total concentration of dissolved osmotically active particles in serum.

Routine calculation estimates the major measured contributors:

• Sodium and accompanying anions
• Glucose
• Urea

If another osmotically active substance is present but is not included in the calculation:

Measured osmolality rises → calculated osmolality does not rise proportionally → osmolal gap increases

This is the principle behind using the gap to detect toxic alcohols.

⸻

Measurement of Serum Osmolality

Serum osmolality should preferably be measured using freezing-point depression.

This method is appropriate for detecting the osmotic effects of volatile alcohols.

Older vapor-pressure techniques may fail to accurately account for volatile substances and are unsuitable when toxic alcohol exposure is suspected.

⸻

Important Toxicologic Causes

Methanol

Methanol itself increases the osmolal gap.

It is metabolized to:

• Formaldehyde
• Formic acid/formate

The metabolites are responsible for much of the severe toxicity.

Clinical manifestations include:

• CNS depression
• Nausea/vomiting
• Abdominal discomfort
• Tachypnea
• High-anion-gap metabolic acidosis
• Visual disturbances

Severe poisoning may cause:

• Blindness
• Seizures
• Coma
• Cardiovascular collapse

⸻

Methanol and Visual Toxicity

Visual manifestations are particularly suggestive of methanol poisoning.

Patients may report:

• Blurred vision
• Reduced visual acuity
• Photophobia
• Visual field abnormalities
• A “snowfield” or “snowstorm” appearance

Severe toxicity can produce optic nerve injury and permanent blindness.

⸻

Ethylene Glycol

Ethylene glycol initially behaves as an osmotically active alcohol and therefore may increase the osmolal gap.

It is subsequently metabolized to toxic acids.

Clinical manifestations may include:

• CNS depression
• Nausea/vomiting
• High-anion-gap metabolic acidosis
• Hypocalcemia
• Acute kidney injury

Calcium oxalate crystalluria may occur but is neither sufficiently sensitive nor specific to exclude or confirm poisoning by itself.

⸻

Isopropanol

Isopropanol is metabolized to acetone.

Clinical manifestations include:

• CNS depression
• Dizziness
• Nausea/vomiting
• Abdominal pain
• Hypotension in severe cases
• Hemorrhagic gastritis

A classic laboratory pattern is:

Elevated osmolal gap + ketosis without significant high-anion-gap metabolic acidosis

This occurs because acetone is a ketone but not a strong organic acid.

⸻

Ethanol

Ethanol is a common cause of an elevated osmolal gap.

It may produce:

• Disinhibition
• Ataxia
• Dysarthria
• CNS depression
• Hypoglycemia, particularly in young children
• Respiratory depression in severe intoxication

When interpreting an osmolal gap for suspected toxic alcohol poisoning, the contribution from ethanol should be considered.

⸻

Propylene Glycol

Propylene glycol is used as a solvent in some medications.

Large or prolonged exposures can cause:

• Elevated osmolal gap
• Lactic acidosis
• CNS depression
• Renal dysfunction

Risk is increased when substantial quantities of propylene-glycol-containing medications are administered, particularly in critically ill patients.

⸻

Osmolal Gap and Anion Gap

The osmolal gap and anion gap provide different information.

The anion gap is commonly calculated as:

Laboratory reference ranges vary depending on measurement methods and whether potassium is included.

⸻

Relationship During Toxic Alcohol Poisoning

Understanding the time course is extremely important.

Early Poisoning

Soon after ingestion, much of the toxic alcohol remains as the parent compound.

Therefore:

Parent alcohol ↑ → osmolal gap ↑

The anion gap may still be normal because relatively little toxic acid metabolite has formed.

⸻

Later Poisoning

As methanol or ethylene glycol is metabolized:

Parent alcohol ↓ → osmolal gap ↓

At the same time:

Toxic organic acids ↑ → anion gap metabolic acidosis ↑

Therefore, the typical progression is:

Early → high osmolal gap, little acidosis

Later → falling osmolal gap, increasing anion-gap acidosis

⸻

Major Diagnostic Pitfall

A normal osmolal gap does NOT exclude methanol or ethylene glycol poisoning.

This is one of the most important concepts.

A patient presenting late may have already metabolized much of the parent alcohol.

Therefore:

Normal osmolal gap + severe high-anion-gap metabolic acidosis can still represent advanced toxic alcohol poisoning.

Clinical suspicion should not be dismissed simply because the osmolal gap has normalized.

⸻

Anion Gap Can Also Be Normal Early

Likewise, a normal anion gap does not exclude an early toxic alcohol exposure.

Before sufficient toxic metabolites accumulate:

• Osmolal gap may already be elevated.
• Anion gap may remain normal.

Thus neither gap should be interpreted independently.

⸻

Clinical Features

The osmolal gap itself causes no symptoms.

Symptoms arise from the substance responsible for the gap.

Possible manifestations include:

• Intoxication
• CNS depression
• Ataxia
• Nausea/vomiting
• Abdominal pain
• Tachypnea
• Hypotension
• Seizures
• Coma

Specific findings can help identify the responsible toxicant.

⸻

Diagnostic Evaluation

When toxic alcohol poisoning is suspected, evaluation may include:

• Measured serum osmolality
• Sodium
• Glucose
• BUN
• Electrolytes
• Bicarbonate
• Anion gap
• Blood gas
• Lactate
• Renal function
• Glucose
• ECG

When available, obtain specific concentrations of:

• Methanol
• Ethylene glycol
• Ethanol
• Isopropanol

Direct measurement of the suspected alcohol is preferable to relying solely on calculated gaps.

⸻

Additional Findings in Ethylene Glycol Poisoning

Consider:

• Hypocalcemia
• Acute kidney injury
• Calcium oxalate crystalluria
• Metabolic acidosis

Renal injury may become prominent later in the course.

⸻

Additional Findings in Methanol Poisoning

Consider:

• Severe metabolic acidosis
• Elevated anion gap
• Visual symptoms
• Optic nerve injury
• CNS deterioration

The combination of:

Unexplained high-anion-gap metabolic acidosis + visual symptoms

should raise strong concern for methanol toxicity.

⸻

Treatment Principles

Treatment depends on the underlying toxicant rather than the osmolal gap itself.

Initial management includes:

• Stabilize airway, breathing, and circulation.
• Correct major metabolic abnormalities.
• Obtain appropriate laboratory studies.
• Identify the suspected exposure.
• Consult a poison center or medical toxicologist when significant toxic alcohol poisoning is suspected.

⸻

Fomepizole

Fomepizole is the preferred antidote for methanol and ethylene glycol poisoning.

It inhibits alcohol dehydrogenase, preventing formation of the toxic metabolites responsible for major organ injury.

Treatment should not necessarily be delayed while awaiting confirmatory concentrations when the exposure history and clinical findings strongly suggest significant methanol or ethylene glycol poisoning.

⸻

Ethanol as an Alternative Antidote

Ethanol also competitively inhibits alcohol dehydrogenase and historically has been used to treat methanol and ethylene glycol poisoning.

However, it is more difficult to use safely because it can cause:

• CNS depression
• Hypoglycemia
• Hypotension
• Variable serum concentrations
• Complex monitoring requirements

Therefore:

Fomepizole is generally preferred.

Ethanol is primarily an alternative when fomepizole is unavailable and should be managed under specialist guidance.

⸻

Hemodialysis

Hemodialysis can rapidly remove:

• Methanol
• Ethylene glycol
• Their toxic metabolites

It also helps correct:

• Severe metabolic acidosis
• Electrolyte abnormalities

Dialysis is particularly important in selected severe poisonings involving features such as:

• Severe metabolic acidosis
• Significant end-organ toxicity
• Visual toxicity from methanol
• Significant renal dysfunction with ethylene glycol
• Severe clinical deterioration
• High toxic alcohol burden

Modern decisions should integrate the clinical condition, acid-base status, renal function, and measured toxic alcohol concentration, rather than relying on a single rigid threshold.

⸻

Isopropanol Treatment

Most isopropanol poisoning is treated with supportive care.

Management may include:

• Airway support
• IV fluids
• Treatment of hypotension
• Management of gastrointestinal irritation

Unlike methanol and ethylene glycol poisoning:

Fomepizole is generally NOT indicated for isolated isopropanol poisoning.

Blocking alcohol dehydrogenase would delay conversion of isopropanol to its less toxic metabolite, acetone.

Hemodialysis is reserved for unusual, exceptionally severe cases.

⸻

Gastrointestinal Decontamination

Activated charcoal is generally not useful for isolated toxic alcohol ingestion because these small alcohol molecules are poorly adsorbed and rapidly absorbed.

Induced vomiting is not recommended.

Routine gastric lavage is also not recommended.

Management should instead focus on:

• Early recognition
• Antidotal therapy when appropriate
• Correction of metabolic abnormalities
• Hemodialysis when indicated

⸻

Monitoring

Significant suspected toxic alcohol poisoning requires serial assessment of:

• Mental status
• Vital signs
• Acid-base status
• Anion gap
• Electrolytes
• Renal function
• Osmolal gap

Specific toxic alcohol concentrations should be followed when available.

A falling osmolal gap should not automatically be interpreted as clinical improvement.

⸻

Expected Course

Methanol and Ethylene Glycol

The parent alcohol initially causes intoxication and an increased osmolal gap.

As metabolism progresses:

• Parent alcohol concentration decreases.
• Osmolal gap falls.
• Toxic metabolites accumulate.
• Metabolic acidosis and organ injury increase.

Early recognition and inhibition of alcohol dehydrogenase substantially reduce toxicity.

Isopropanol

Usually causes relatively rapid intoxication and ketosis.

Most patients recover with supportive care, although severe exposures can cause:

• Profound CNS depression
• Hypotension
• Hemorrhagic gastritis

⸻

Key Points

• The osmolal gap = measured serum osmolality − calculated serum osmolality.
• It is a screening clue for unmeasured osmotically active substances.
• Important toxicologic causes include methanol, ethylene glycol, isopropanol, ethanol, propylene glycol, and acetone.
• An elevated osmolal gap is not specific for toxic alcohol poisoning.
• A normal osmolal gap does not exclude methanol or ethylene glycol poisoning.
• Early methanol/ethylene glycol poisoning may produce a high osmolal gap with little or no anion-gap acidosis.
• As toxic alcohol metabolism progresses, the osmolal gap falls while the anion gap rises.
• Methanol classically causes visual toxicity and severe metabolic acidosis.
• Ethylene glycol can cause metabolic acidosis, hypocalcemia, calcium oxalate crystalluria, and acute kidney injury.
• Isopropanol classically produces ketosis without significant high-anion-gap metabolic acidosis.
• Direct toxic alcohol concentrations are preferable when available.
• Fomepizole is the preferred antidote for methanol and ethylene glycol poisoning.
• Fomepizole is generally not indicated for isolated isopropanol poisoning.
• Hemodialysis is an important treatment for selected severe methanol and ethylene glycol poisonings.
• Activated charcoal is generally ineffective for isolated toxic alcohol ingestion.
• Never interpret the osmolal gap alone; combine it with the exposure history, clinical findings, anion gap, acid-base status, and specific toxicant concentrations when available.

Toxicology – High-Risk Low-Dose Pediatric Poisoning

Definition

High-risk low-dose pediatric poisoning refers to accidental exposure to medications or chemicals capable of producing severe or potentially fatal toxicity after ingestion of a relatively small amount by a young child.

Young children are particularly susceptible because their low body weight means that even a single adult-strength tablet or small volume of a concentrated product may represent a substantial weight-adjusted toxic exposure.

Although most accidental childhood ingestions cause minimal toxicity, certain substances have:

• A narrow therapeutic index
• High intrinsic toxicity
• Potent cardiovascular or neurologic effects
• Delayed toxicity
• Long duration of action

These exposures require careful assessment even when the child is initially asymptomatic.

Major High-Risk Drug Classes

Sulfonylureas

Sulfonylureas are important causes of severe pediatric hypoglycemia.

Examples include:

• Glyburide/glibenclamide
• Glipizide
• Glimepiride
• Gliclazide

A relatively small exposure may stimulate excessive pancreatic insulin release.

Clinical manifestations include:

• Sweating
• Pallor
• Irritability
• Lethargy
• Confusion
• Seizures
• Coma

Hypoglycemia may be delayed, prolonged, or recurrent.

Treatment includes correction of hypoglycemia, with octreotide used in clinically significant sulfonylurea poisoning to suppress further insulin secretion.

Opioids

Young children are highly susceptible to opioid-induced respiratory depression.

Important agents include:

• Methadone
• Codeine
• Hydrocodone
• Other potent or long-acting opioids

Typical findings include:

• CNS depression
• Miosis
• Bradypnea
• Hypoventilation
• Bradycardia
• Hypotension

The most dangerous manifestation is respiratory failure.

Naloxone is indicated when clinically significant opioid-induced respiratory depression is present.

The therapeutic goal is restoration of adequate ventilation rather than complete awakening.

Clonidine and Imidazoline Agents

Clonidine and related imidazolines may cause substantial toxicity following a small pediatric exposure.

Clinical findings include:

• Somnolence
• Miosis
• Bradycardia
• Hypotension
• Respiratory depression

The syndrome may closely resemble opioid toxicity.

An early transient hypertensive phase can occasionally occur.

Tricyclic Antidepressants

Tricyclic antidepressants can produce rapidly progressive neurologic and cardiovascular toxicity.

Examples include:

• Amitriptyline
• Imipramine
• Desipramine

Clinical manifestations include:

• Anticholinergic findings
• Altered mental status
• Seizures
• Hypotension
• QRS widening
• Ventricular dysrhythmias

Severe cardiotoxicity primarily results from fast sodium-channel blockade.

Significant sodium-channel cardiotoxicity is treated with sodium bicarbonate.

Calcium Channel Blockers

Calcium channel blockers can cause severe cardiovascular poisoning.

Important agents include:

• Verapamil
• Diltiazem
• Nifedipine

Manifestations include:

• Bradycardia
• AV conduction abnormalities
• Myocardial depression
• Peripheral vasodilation
• Hypotension
• Cardiogenic or mixed shock

Hyperglycemia is an important clue to significant calcium channel blocker toxicity.

Extended-release preparations may produce delayed and prolonged toxicity.

Severe poisoning may require:

• Calcium
• Vasopressors
• Hyperinsulinemic euglycemia therapy
• Advanced circulatory support

Beta-Adrenergic Blockers

Beta-blocker poisoning may produce:

• Bradycardia
• Hypotension
• AV block
• Reduced myocardial contractility
• CNS depression

Some beta-blockers may additionally cause:

• Seizures
• QRS widening
• Ventricular dysrhythmias

Hypoglycemia can occur, particularly in young children.

Severe cases may require vasopressors and hyperinsulinemic euglycemia therapy, with other therapies selected according to the specific beta-blocker and clinical syndrome.

Antimalarial Agents

Certain antimalarial medications can cause profound cardiovascular toxicity following relatively small pediatric exposures.

Important examples include:

• Chloroquine
• Hydroxychloroquine
• Quinine

Severe toxicity may cause:

• Hypotension
• QRS widening
• QT abnormalities
• Ventricular dysrhythmias
• Seizures
• Hypokalemia
• Cardiovascular collapse

These exposures require urgent medical assessment.

Theophylline

Theophylline has a narrow therapeutic index.

Toxicity may produce:

• Nausea and vomiting
• Tremor
• Agitation
• Tachycardia
• Hypokalemia
• Hyperglycemia
• Seizures
• Ventricular dysrhythmias

Extended-release preparations can cause delayed and prolonged toxicity.

Diphenoxylate

Diphenoxylate-containing antidiarrheal medications can produce opioid-like toxicity in children.

Manifestations include:

• CNS depression
• Miosis
• Respiratory depression
• Bradycardia

Toxicity may be delayed or prolonged.

Naloxone may reverse clinically significant opioid effects.

High-Risk Small-Volume Chemical Exposures

Methanol

Methanol is metabolized to toxic metabolites that can produce:

• High-anion-gap metabolic acidosis
• Visual impairment
• CNS depression
• Seizures
• Coma

Severe poisoning can cause permanent visual and neurologic injury.

Fomepizole inhibits toxic metabolite formation.

Severe poisoning may require hemodialysis.

Ethylene Glycol

Ethylene glycol metabolism produces toxic organic acids.

Clinical manifestations may include:

• CNS depression
• High-anion-gap metabolic acidosis
• Hypocalcemia
• Acute kidney injury

Treatment includes fomepizole, supportive care, and hemodialysis in severe cases.

Methyl Salicylate

Methyl salicylate, commonly found in oil of wintergreen, is a highly concentrated salicylate preparation.

Significant poisoning can produce:

• Vomiting
• Tachypnea
• Diaphoresis
• Tinnitus
• Respiratory alkalosis
• High-anion-gap metabolic acidosis
• Hyperthermia
• Altered mental status

Serial salicylate concentrations and acid-base assessment are important.

Severe toxicity may require urinary alkalinization and hemodialysis.

Camphor

Camphor can produce rapid CNS toxicity.

Manifestations include:

• Nausea
• Vomiting
• Agitation
• Confusion
• Seizures

Neurologic deterioration may occur rapidly after exposure.

Hydrofluoric Acid and Fluoride Compounds

Concentrated fluoride exposure can produce both local tissue injury and severe systemic electrolyte abnormalities.

Potential complications include:

• Hypocalcemia
• Hypomagnesemia
• Hyperkalemia
• QT prolongation
• Ventricular dysrhythmias
• Cardiovascular collapse

These exposures require urgent assessment and correction of electrolyte abnormalities.

Corrosive Substances

Concentrated acids and alkalis may cause severe injury even after relatively small exposures.

Potential complications include:

• Oropharyngeal injury
• Airway edema
• Esophageal burns
• Gastric injury
• Perforation
• Later stricture formation

The absence of oral burns does not exclude significant esophageal injury.

Do not induce vomiting or attempt chemical neutralization.

Activated charcoal generally has no role in corrosive ingestion.

Organophosphate Insecticides

Concentrated organophosphate exposure causes excessive acetylcholine accumulation.

Muscarinic manifestations include:

• Miosis
• Salivation
• Lacrimation
• Bronchorrhea
• Bronchospasm
• Vomiting
• Diarrhea
• Bradycardia

Nicotinic manifestations include:

• Fasciculations
• Weakness
• Paralysis

Severe poisoning can cause respiratory failure.

Treatment includes atropine, supportive respiratory care, and pralidoxime for significant organophosphate poisoning.

Paraquat

Paraquat poisoning can cause severe multisystem toxicity.

Early manifestations may include:

• Oral and gastrointestinal corrosive injury
• Nausea
• Vomiting
• Abdominal pain

Severe poisoning may progress to:

• Acute kidney injury
• Hepatic injury
• Progressive pulmonary toxicity
• Multiorgan failure

Suspected ingestion requires immediate specialist toxicology assessment.

Concentrated Hydrogen Peroxide

Highly concentrated hydrogen peroxide can release large quantities of oxygen after contact with tissues.

Potential complications include:

• Gastrointestinal irritation
• Gastric distension
• Mucosal injury
• Gas embolism
• Neurologic complications
• Cardiovascular instability

Toxicity depends strongly on the concentration and amount of product involved.

Amatoxin-Containing Mushrooms

Certain mushrooms, particularly Amanita phalloides and related amatoxin-containing species, can cause severe hepatic toxicity.

Typical progression:

Latent asymptomatic phase → severe gastroenteritis → temporary clinical improvement → hepatic failure

The apparent improvement after gastrointestinal symptoms can be misleading.

Severe cases may progress to:

• Coagulopathy
• Hypoglycemia
• Encephalopathy
• Multiorgan failure

Lead-Containing Foreign Bodies

Ingested lead-containing objects can cause significant toxicity when retained within the gastrointestinal tract.

Potential consequences include:

• Elevated blood lead concentrations
• Abdominal symptoms
• Neurologic toxicity
• Hematologic abnormalities

Management depends on the location and retention of the object, blood lead concentration, and clinical condition.

Major Toxicologic Syndromes

Respiratory Depression

Important causes:

• Opioids
• Clonidine/imidazolines
• Diphenoxylate

Clinical priority:

Assess ventilation and airway protection.

Hypoglycemia

Important cause:

• Sulfonylureas

Because hypoglycemia may recur, serial glucose monitoring is essential.

Cardiovascular Toxicity

Important causes:

• Tricyclic antidepressants
• Calcium channel blockers
• Beta-blockers
• Chloroquine/hydroxychloroquine

Possible manifestations:

• Bradycardia
• Conduction abnormalities
• QRS widening
• Dysrhythmias
• Hypotension
• Shock

Seizures

Important toxicologic causes include:

• Tricyclic antidepressants
• Theophylline
• Camphor
• Chloroquine
• Stimulants

Seizures may contribute to:

• Hyperthermia
• Lactic acidosis
• Rhabdomyolysis
• Hypoxia

Delayed Organ Toxicity

Important causes include:

• Methanol
• Ethylene glycol
• Amatoxin-containing mushrooms
• Paraquat
• Extended-release medications

Therefore, the absence of early symptoms does not necessarily indicate a benign exposure.

Evaluation of the Initially Asymptomatic Child

A normal initial examination does not reliably exclude serious poisoning.

Delayed toxicity can result from:

• Extended-release formulations
• Delayed gastrointestinal absorption
• Formation of toxic metabolites
• Long drug half-lives
• Recurrent hypoglycemia
• Delayed hepatic, renal, or pulmonary injury

Observation should therefore be determined by the specific toxicant and formulation, rather than using a universal observation period.

Exposure History

Important information includes:

• Exact medication or chemical
• Active ingredient
• Formulation
• Concentration or tablet strength
• Immediate-release versus extended-release preparation
• Child’s weight
• Maximum possible amount involved
• Time of exposure
• Presence of coingestants
• Current symptoms

Whenever possible, the original medication or product container should be identified.

Initial Clinical Assessment

Evaluate:

• Airway patency
• Respiratory rate and effort
• Ventilation
• Oxygenation
• Mental status
• Heart rate
• Blood pressure
• Temperature
• Pupils
• Neuromuscular findings

A bedside blood glucose should be obtained early in unexplained altered mental status, seizures, or suspected hypoglycemic-agent exposure.

ECG Assessment

ECG monitoring is particularly important with suspected:

• Tricyclic antidepressants
• Sodium-channel blockers
• Beta-blockers
• Calcium channel blockers
• Chloroquine/hydroxychloroquine
• Other cardiotoxic medications

Important abnormalities include:

• Bradycardia
• AV block
• QRS widening
• QT prolongation
• Ventricular dysrhythmias

Laboratory Evaluation

Testing should be directed by the suspected exposure.

Possible studies include:

• Glucose
• Electrolytes
• Renal function
• Blood gas
• Lactate
• Acetaminophen concentration when indicated
• Salicylate concentration
• Toxic alcohol evaluation
• Drug-specific concentrations when clinically useful

Routine broad toxicology screening should not replace a careful exposure history and targeted testing.

Management Principles

The general approach is:

Identify exposure → assess ABCs → recognize expected toxidrome → anticipate delayed toxicity → initiate specific/supportive treatment → monitor appropriately

Potentially dangerous pediatric ingestions can deteriorate rapidly despite an initially normal examination.

Gastrointestinal Decontamination

Induced vomiting is not recommended.

Routine gastric lavage is generally not indicated.

Activated charcoal may be considered for selected potentially serious recent ingestions when:

• The substance is effectively adsorbed,
• A meaningful clinical benefit is expected, and
• The airway is adequately protected.

Decontamination should never delay stabilization or administration of an urgently required antidote.

Observation and Disposition

Observation duration should be toxicant-specific.

Prolonged monitoring may be required for:

• Extended-release medications
• Sulfonylureas
• Long-acting opioids
• Calcium channel blockers
• Toxic alcohols
• Substances causing delayed organ injury

Symptomatic patients or children with potentially serious exposures generally require monitored medical evaluation.

Key Points

• High-risk low-dose pediatric poisoning is a more clinically descriptive term for the traditional “one pill can kill” concept.
• It describes medications or chemicals capable of producing severe toxicity from relatively small pediatric exposures.
• Young children are particularly vulnerable because a small absolute amount may represent a large weight-adjusted dose.
• Important high-risk medications include sulfonylureas, opioids, clonidine, TCAs, calcium channel blockers, beta-blockers, antimalarials, and theophylline.
• Sulfonylureas can cause delayed and recurrent hypoglycemia.
• Opioids and clonidine can cause CNS and respiratory depression.
• TCAs and other cardiotoxic medications can cause seizures, conduction abnormalities, dysrhythmias, and shock.
• Small-volume chemical exposures can also be dangerous, particularly toxic alcohols, concentrated salicylates, corrosives, hydrofluoric acid, paraquat, and concentrated hydrogen peroxide.
• Some dangerous poisonings have an initially asymptomatic period.
• Obtain the exact product, formulation, strength, timing, maximum possible exposure, and child’s weight.
• Observation and treatment should be based on the specific toxicant and its pharmacokinetics, rather than a universal “one-pill” rule.